hg_93524.1

Basic information about the TSS

---

TSS ID: hg_93524.1 Species: human Chr: chr8		Start: 70608152 End: 70608163 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: CR541739 BT007359 CR541654 Distance: -36 GeneID: 23471 HGNC/MGI_ID: HGNC:20568 UniProt_ID: Q6FHU7

Gene_name: translocation associated membrane protein 1 Gene_symbol: TRAM1 Gene_synonyms: TRAM TRAMP Gene_source: HGNC:20568

TATA-Box annotation

---

Distance to TSS:	258
Nearest PromoterID:	NM_001317804
Entrez ID:	23471
Nearest Unigene:	Hs.491988
Nearest Refseq:	NM_014294
Nearest Ensembl:	ENSG00000067167
Gene Name:	translocation associated membrane protein 1
Gene Alias:	PNAS8|TRAM|TRAMP
Gene Description:	translocation associated membrane protein 1
Gene Type:	protein-coding
CpG%:	0.08
GC%:	0.651741
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TRAM1 p2@TRAM1 p3@TRAM1 p4@TRAM1 p5@TRAM1 p7@TRAM1
Sample		p1@TRAM1	p2@TRAM1	p3@TRAM1	p4@TRAM1	p5@TRAM1	p7@TRAM1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	80.45	9.55	3.31	5.06	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	85.58	7.89	3.84	7.28	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	89.51	10.42	5.21	7.91	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	68.82	8.94	3.95	5.20	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	75.59	11.70	2.47	6.30	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	79.07	7.75	2.52	7.56	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	117.87	11.33	6.97	6.97	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	84.53	10.42	5.33	9.45	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	94.04	11.11	4.49	7.91	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	57.38	4.64	4.06	8.11	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	48.91	4.85	2.83	6.87	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	55.70	4.07	4.07	3.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	85.59	10.16	3.71	6.13	0.97	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	82.54	7.67	5.71	4.51	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	80.80	7.46	3.95	3.95	1.32	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	67.65	8.05	3.02	4.28	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	62.25	6.33	3.49	5.02	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	69.18	4.22	3.80	1.69	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	48.52	5.86	3.20	4.80	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	71.46	7.52	4.66	5.42	0.90	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	83.40	9.09	4.54	5.61	0.53	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	75.95	9.32	4.66	4.49	0.86	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	74.58	7.50	3.75	4.39	0.65	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	71.59	5.10	2.18	4.13	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	75.08	8.00	4.90	4.13	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	71.22	7.60	2.22	4.11	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	56.04	6.04	2.20	2.75	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	78.74	8.02	6.60	4.95	1.65	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	71.23	7.11	5.49	4.04	2.10	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	71.48	5.79	5.79	5.25	0.36	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	62.59	8.37	3.14	3.56	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	58.81	6.64	5.28	4.30	1.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	74.92	6.96	4.64	2.74	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	77.19	9.57	6.10	4.45	0.49	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	70.87	6.54	5.05	4.11	1.31	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	64.19	7.28	3.83	4.98	0.77	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	74.39	8.58	5.52	6.74	1.43	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	67.70	6.65	4.63	4.23	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	84.54	9.18	7.29	5.94	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	80.66	7.68	5.28	7.20	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	71.99	5.65	5.18	5.41	1.18	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	88.42	9.81	6.00	5.86	1.02	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	68.12	7.17	6.12	5.48	2.11	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	74.48	7.52	5.42	5.94	0.87	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	95.97	7.03	9.24	7.63	1.41	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	91.66	9.77	6.28	6.51	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	79.17	5.28	7.92	6.72	2.40	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	93.29	7.45	8.35	6.56	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	87.61	10.29	5.51	6.70	1.91	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	82.29	9.50	7.08	8.09	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	82.39	10.86	8.61	5.53	1.43	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	102.29	12.68	8.45	9.12	2.67	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	13.99	13.99	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	94.04	13.84	5.68	7.45	1.42	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	76.88	12.26	4.31	8.28	1.66	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	106.55	20.97	7.55	10.07	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	113.43	12.86	5.51	10.10	1.38	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	74.22	9.72	8.43	6.16	2.59	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	70.01	12.85	8.67	6.74	3.21	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	109.70	15.09	8.80	9.12	2.51	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	69.10	9.17	7.76	3.53	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	83.56	12.34	9.53	8.41	0.56	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	106.68	13.53	7.17	6.37	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	102.95	11.21	7.14	6.80	2.38	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	70.18	11.37	6.50	6.50	3.25	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	66.03	11.00	4.97	8.52	2.13	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	210.13	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	150.05	23.69	39.49	23.69	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	87.75	16.09	2.44	5.85	1.95	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	101.16	11.90	5.45	2.98	3.47	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	95.70	18.76	4.69	7.97	3.28	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	110.29	14.57	3.97	4.64	3.97	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	79.81	10.83	6.81	7.11	2.78	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	88.36	13.76	5.81	3.97	2.75	2.14
Adipocyte - breast, donor1	11376-118A8	280.50	22.49	11.72	14.41	2.53	0.95
Adipocyte - breast, donor2	11327-117E4	184.65	10.91	8.02	11.87	1.93	0.64
Adipocyte - omental, donor1	11473-119C6	308.27	28.37	13.61	18.45	3.05	0.38
Adipocyte - omental, donor2	11474-119C7	189.86	11.96	6.73	12.71	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	133.30	11.72	7.03	8.37	2.01	1.34
Adipocyte - perirenal, donor1	11476-119C9	160.77	8.29	13.40	11.48	1.28	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	29.69	6.60	2.20	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	121.04	11.29	2.26	4.06	1.81	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	78.72	5.56	2.26	2.43	1.22	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	208.28	28.55	9.78	7.04	2.54	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	124.06	19.05	5.92	5.66	2.06	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	166.98	13.66	5.30	9.48	1.39	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	119.33	19.99	8.82	7.64	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	110.11	20.75	6.27	8.61	1.85	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	102.64	14.52	9.36	6.78	1.94	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	82.11	12.26	7.46	7.46	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	74.56	10.57	2.78	6.68	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	64.05	13.31	4.57	7.07	2.08	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	86.15	14.32	5.02	6.03	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	97.19	6.54	7.85	6.87	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	49.02	10.66	2.44	5.78	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	195.58	14.59	5.97	11.49	1.10	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	37.29	2.15	1.43	2.87	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	26.36	1.20	0.00	1.20	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	39.40	11.51	5.58	2.16	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	6.69	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	32.87	5.75	3.29	2.26	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	358.84	23.34	12.13	20.83	2.17	1.49
Anulus Pulposus Cell, donor2	11463-119B5	288.26	12.49	15.67	20.57	2.45	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	66.05	6.29	7.64	3.15	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	74.67	7.81	8.68	9.55	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	47.09	14.98	14.98	6.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	74.73	9.27	5.68	6.28	0.90	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	84.73	5.06	7.59	8.85	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	54.79	9.24	3.96	5.94	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	62.38	6.17	4.55	5.20	0.32	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	82.52	7.77	3.40	5.34	1.46	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	62.95	11.88	6.53	2.97	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	68.17	10.55	4.52	3.77	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	79.10	8.71	5.08	2.90	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	53.91	6.27	7.52	3.76	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	116.30	17.79	8.90	9.55	1.81	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	72.33	10.92	0.00	4.09	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	78.41	14.02	8.29	7.99	1.21	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	72.33	9.11	6.97	8.04	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	91.82	10.58	6.05	6.42	0.94	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	77.51	9.09	6.15	3.47	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	74.13	12.68	0.98	3.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	80.77	10.12	8.29	5.97	1.99	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	76.85	4.80	4.80	4.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	63.72	10.62	14.16	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	94.34	8.06	7.20	8.06	0.69	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	50.34	0.00	4.19	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	80.10	10.19	6.31	4.37	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	98.28	9.49	8.73	8.73	1.90	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	59.36	9.69	6.06	3.63	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	72.39	9.12	3.42	6.84	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	86.37	8.98	8.12	8.76	1.07	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	71.75	11.61	5.42	5.68	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	63.81	5.16	5.63	7.98	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	72.03	10.29	5.47	4.50	0.96	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	51.37	7.13	4.99	2.14	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	52.65	8.19	6.43	1.75	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	78.58	10.84	7.53	6.62	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	52.27	5.94	9.50	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	58.99	8.14	5.09	6.61	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	74.11	7.39	5.35	4.58	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	55.91	8.26	6.99	4.45	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	68.18	6.04	5.18	4.75	1.73	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	78.75	9.95	7.62	5.72	0.42	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	59.45	6.09	6.38	5.51	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	62.35	5.67	8.50	6.61	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	80.69	8.98	6.95	6.44	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	64.86	6.95	11.58	2.32	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	103.52	8.45	2.11	4.23	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	92.20	9.22	7.50	4.93	1.07	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	68.59	15.64	7.82	5.41	1.80	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	67.79	3.64	6.56	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	82.99	10.11	6.67	6.90	1.61	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	73.96	17.85	5.10	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	100.17	16.78	7.63	9.66	1.02	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	95.17	11.56	8.67	8.05	1.03	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	59.06	7.04	6.73	3.98	1.22	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	67.88	13.86	6.69	4.78	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	84.04	9.98	8.43	5.54	2.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	56.45	15.26	4.58	10.68	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	75.88	9.42	5.54	1.66	2.22	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	84.20	11.65	8.47	5.83	1.06	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	69.06	10.18	4.72	5.09	2.54	0.00
Astrocyte - cerebellum, donor1	11500-119F6	36.48	9.33	1.97	1.47	0.25	0.25
Astrocyte - cerebellum, donor2	11580-120F5	35.43	4.11	2.05	2.40	0.68	0.51
Astrocyte - cerebellum, donor3	11661-122F5	18.88	4.40	1.05	1.47	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	65.53	18.13	6.27	2.79	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	49.50	12.46	6.63	3.88	0.49	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	76.97	16.41	7.01	5.97	1.19	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	92.44	4.82	3.78	5.05	0.80	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	90.20	5.89	4.89	3.51	0.25	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	89.67	8.53	3.53	3.30	1.02	0.00
Basophils, donor1	12241-129G9	105.92	7.85	3.14	5.49	3.40	2.09
Basophils, donor2	12242-129H1	244.26	14.79	8.66	10.46	4.33	2.53
Basophils, donor3	12243-129H2	148.03	11.91	6.03	7.64	3.67	1.32
Bronchial Epithelial Cell, donor1	11511-119G8	35.14	3.02	3.02	1.72	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	8.23	0.91	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	14.35	0.00	14.35	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	54.61	4.39	1.88	2.51	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	28.91	3.54	3.33	1.04	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	37.31	4.15	2.30	0.23	1.15	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	84.03	11.52	3.06	4.86	0.54	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	103.06	6.08	15.97	14.84	0.41	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	137.41	8.62	33.07	19.10	1.86	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	143.26	19.51	11.51	11.19	2.88	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	144.79	51.71	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	156.10	9.58	2.82	10.71	8.45	3.94
CD14+ Monocytes, donor2	11305-117B9	101.15	6.68	3.71	4.64	4.45	1.48
CD14+ Monocytes, donor3	11381-118B4	117.01	8.78	3.95	5.49	5.27	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	208.60	13.87	10.76	13.02	2.55	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	204.32	16.68	12.51	19.33	3.03	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	259.70	20.38	11.83	9.20	0.99	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	120.26	7.08	5.20	10.41	2.02	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	91.13	9.35	6.64	6.34	1.81	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	111.34	7.82	9.00	7.82	1.18	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	79.85	3.68	4.52	6.19	2.34	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	74.52	8.00	3.59	6.35	1.93	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	81.57	7.93	3.97	2.98	1.24	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	74.21	4.50	3.13	6.66	1.76	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	80.83	6.59	3.56	5.34	0.71	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	113.17	10.45	2.39	6.31	2.18	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	77.03	5.15	2.81	4.45	4.92	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	92.40	9.50	3.17	7.39	2.64	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	75.44	6.66	2.22	4.44	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	99.96	7.44	6.25	6.84	1.64	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	77.03	5.39	5.39	4.99	0.80	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	123.46	10.20	5.62	8.12	1.25	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	93.57	3.66	4.80	7.09	4.12	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	95.46	6.11	4.30	7.69	2.71	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	71.58	3.06	3.93	5.24	3.49	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	88.50	7.80	8.61	10.22	1.34	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	109.74	10.29	6.46	8.90	1.22	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	103.52	11.36	7.57	6.73	2.95	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	85.98	6.61	2.02	3.31	2.02	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	75.03	7.40	4.93	5.99	4.23	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	71.07	5.70	3.95	5.70	3.07	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	77.95	4.53	3.49	3.66	1.39	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	80.65	10.78	1.86	4.09	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	112.09	7.76	6.04	7.33	4.10	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	99.10	5.73	3.69	5.32	1.64	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	84.84	7.19	3.71	4.40	2.78	1.62
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	99.76	7.66	5.10	4.41	2.55	1.62
CD14+CD16+ Monocytes, donor1	11789-124B7	132.52	12.64	5.01	8.94	0.44	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	129.82	10.39	4.62	4.16	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	134.30	9.96	5.63	9.75	0.65	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	153.85	7.94	8.56	9.34	1.87	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	132.21	8.56	9.08	9.95	0.87	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	182.39	14.94	9.81	11.37	1.78	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	109.73	3.83	5.61	5.87	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	124.71	8.56	4.61	9.66	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	134.33	14.95	4.84	7.16	0.63	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	199.17	16.26	16.26	8.13	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	167.46	17.63	13.56	10.17	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	181.23	11.39	12.43	11.39	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	222.28	20.79	11.73	13.33	1.60	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	220.32	25.20	9.65	16.08	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	172.68	15.44	10.53	9.83	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	181.97	14.12	10.98	8.63	1.57	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	185.88	19.77	9.23	15.82	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	105.20	10.68	1.64	5.75	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	115.34	18.86	7.98	4.35	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	99.45	19.18	3.53	4.04	2.52	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	45.25	48.89	3.64	3.23	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	34.76	41.95	2.40	0.80	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	68.28	13.05	2.01	2.01	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	129.78	11.80	6.18	9.55	7.30	4.49
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	139.41	23.30	13.90	6.76	2.25	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	163.70	25.93	11.05	11.50	2.25	1.13
CD4+ T Cells, donor1	11225-116C1	259.22	15.00	9.28	12.50	3.57	0.36
CD4+ T Cells, donor2	11306-117C1	214.94	12.86	10.41	9.19	2.45	0.61
CD4+ T Cells, donor3	11382-118B5	220.21	14.64	10.98	9.76	5.18	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	154.42	11.74	6.89	4.85	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	148.01	16.84	6.74	5.17	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	132.81	15.81	3.74	4.89	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	161.19	15.65	5.69	7.11	1.90	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	167.15	12.64	4.92	7.02	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	154.92	16.48	9.89	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	187.58	10.12	8.38	9.97	1.30	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	117.78	9.83	7.46	6.27	0.51	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	104.62	11.45	5.48	4.51	0.97	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	187.84	17.04	9.41	7.17	1.34	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	191.46	18.52	7.69	8.73	0.35	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	198.87	15.40	3.96	8.36	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	138.30	13.07	13.49	5.90	2.11	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	117.81	8.52	8.10	8.93	1.66	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	118.28	8.02	5.35	4.68	2.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	183.01	10.61	8.43	8.70	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	187.58	13.93	4.29	6.97	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	170.36	8.97	7.17	1.79	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	192.29	10.20	11.31	10.75	0.93	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	148.17	8.45	13.65	10.18	1.52	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	154.67	9.88	10.51	6.72	2.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	174.43	7.08	7.08	7.08	1.52	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	177.63	8.67	9.10	9.53	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	227.93	9.59	12.64	11.77	1.31	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	293.95	18.31	20.29	16.33	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	240.95	19.39	15.69	8.31	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	252.64	12.56	11.17	6.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	248.68	13.57	17.17	11.91	0.55	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	302.08	21.35	18.16	20.61	0.98	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	272.58	18.48	24.64	10.78	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	273.24	14.32	16.12	15.40	2.15	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	277.00	18.00	19.39	8.31	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	294.33	13.42	12.11	9.49	6.55	2.95
CD8+ T Cells, donor2	11307-117C2	205.74	9.39	12.01	10.14	4.13	0.75
CD8+ T Cells, donor3	11383-118B6	226.23	18.43	9.34	5.05	4.04	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	60.79	11.01	1.38	2.06	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	53.68	5.99	0.96	1.92	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	54.72	7.39	2.19	3.01	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	47.43	6.00	3.90	2.10	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	57.84	10.08	2.16	2.40	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	55.94	10.91	2.27	2.27	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	57.36	9.34	1.30	2.39	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	55.80	16.85	1.58	2.37	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	63.79	10.79	2.81	2.11	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	64.30	10.57	1.21	3.62	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	68.27	8.13	2.03	2.91	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	63.94	11.19	2.66	4.26	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	52.09	6.13	3.50	5.25	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	56.93	5.01	3.64	6.38	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	44.01	7.46	3.73	5.22	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	63.39	11.16	1.80	2.16	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	58.70	10.36	1.15	2.59	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	54.92	7.31	1.89	2.12	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	71.30	9.51	2.22	2.54	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	62.44	10.46	3.08	2.46	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	66.36	9.30	2.24	3.53	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	66.55	9.94	1.91	1.53	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	69.36	5.91	3.55	3.15	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	52.95	9.08	3.03	4.54	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	101.17	7.23	5.62	8.83	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	102.12	4.20	4.20	9.09	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	88.15	7.01	8.01	11.02	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	93.21	21.93	5.48	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	71.15	9.39	2.96	4.45	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	214.99	17.78	12.42	13.79	2.42	1.05
Chondrocyte - de diff, donor1	11261-116G1	191.01	10.75	15.25	16.29	2.08	1.39
Chondrocyte - de diff, donor2	11338-117F6	201.50	15.28	9.24	17.77	2.13	0.71
Chondrocyte - de diff, donor3	11410-118E6	361.59	14.11	18.32	23.10	1.71	1.02
Chondrocyte - re diff, donor2	11339-117F7	215.76	18.80	13.43	12.53	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	165.81	17.79	5.66	6.87	3.24	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	98.12	12.39	7.34	4.71	1.03	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	90.42	7.91	4.92	5.34	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	87.44	10.27	7.61	4.42	1.15	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	111.32	31.55	7.79	7.61	2.20	0.92
Corneal Epithelial Cells, donor1	11526-119I5	14.71	1.76	0.44	0.22	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	20.48	2.28	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	13.80	3.07	2.30	0.26	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	108.96	5.12	5.94	5.45	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	111.65	5.68	2.84	7.57	0.32	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	113.87	3.45	13.80	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	107.02	4.97	5.29	5.51	1.19	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	341.30	18.79	83.02	62.52	12.64	4.44
Dendritic Cells - plasmacytoid, donor2	11309-117C4	460.27	25.46	84.87	58.76	33.30	5.22
Dendritic Cells - plasmacytoid, donor3	11385-118B8	395.38	15.49	100.18	65.82	14.03	4.84
Endothelial Cells - Aortic, donor0	11207-116A1	76.55	11.84	5.84	3.17	1.50	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	31.10	9.98	2.35	2.35	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	65.04	12.44	3.96	4.81	1.13	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	68.81	14.15	3.93	3.15	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	38.69	5.53	2.62	1.75	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	60.94	11.53	3.06	2.59	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	53.12	9.64	4.56	3.33	0.53	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	108.83	13.96	6.21	5.98	2.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	131.75	18.56	8.22	6.09	1.83	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	148.56	18.04	9.02	8.46	1.97	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	58.83	10.70	5.35	3.27	1.78	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	51.55	11.98	2.08	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	37.43	6.66	3.97	3.40	0.71	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	93.23	24.81	8.80	9.20	1.20	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	35.64	4.19	1.57	1.57	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	119.90	23.61	9.07	7.83	2.86	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	66.70	16.51	4.56	4.35	1.74	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	85.00	22.96	3.18	3.18	2.44	0.73
Endothelial Cells - Vein, donor1	11267-116G7	42.09	3.41	2.28	2.28	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	46.10	13.27	2.79	2.10	1.40	0.70
Endothelial Cells - Vein, donor3	11416-118F3	61.39	10.68	5.34	4.87	1.41	0.31
Eosinophils, donor1	12244-129H3	442.16	45.74	45.74	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	193.08	4.95	6.60	13.20	1.65	0.00
Eosinophils, donor3	12246-129H5	124.84	3.57	3.57	14.27	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	36.16	5.38	1.47	1.22	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	29.12	4.16	0.00	4.16	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	130.15	16.27	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	174.06	13.55	9.03	16.83	0.82	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	80.36	8.43	6.13	7.34	0.55	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	57.74	8.88	1.84	2.49	1.84	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	157.66	13.70	11.89	11.16	1.21	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	192.83	8.05	14.88	14.06	0.55	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	169.28	9.28	8.44	10.02	1.27	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	221.60	9.49	18.97	18.97	1.32	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	127.90	13.62	6.64	7.64	0.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	105.70	8.17	10.43	7.71	1.36	0.45
Fibroblast - Cardiac, donor2	11345-117G4	75.79	12.13	3.03	4.55	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	67.03	6.31	6.62	6.31	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	193.08	22.73	10.00	10.91	2.73	0.91
Fibroblast - Cardiac, donor5	11456-119A7	105.08	11.68	7.61	5.84	2.03	1.27
Fibroblast - Cardiac, donor6	11460-119B2	84.44	11.67	5.15	4.70	1.82	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	115.77	11.12	10.99	8.31	1.47	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	94.91	8.20	9.06	8.20	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	111.32	11.72	2.93	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	35.98	8.07	2.54	1.61	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	152.98	20.35	18.66	13.57	2.54	1.02
Fibroblast - Dermal, donor1	11269-116G9	62.69	8.92	5.17	3.05	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	47.64	11.79	3.77	0.94	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	81.60	13.42	5.80	3.87	1.69	0.36
Fibroblast - Dermal, donor4	11450-119A1	52.11	11.19	2.26	2.15	2.03	0.11
Fibroblast - Dermal, donor5	11454-119A5	64.37	15.18	4.19	2.79	1.92	0.70
Fibroblast - Dermal, donor6	11458-119A9	64.64	18.03	4.22	1.46	1.14	1.14
Fibroblast - Gingival, donor1	11237-116D4	169.08	22.91	10.41	8.54	0.83	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	256.24	25.94	21.22	14.67	2.10	0.79
Fibroblast - Gingival, donor2	11318-117D4	88.95	19.24	5.80	4.09	0.79	0.53
Fibroblast - Gingival, donor3	11394-118C8	139.23	14.60	10.83	9.57	0.87	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	451.92	29.09	27.01	27.01	4.16	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	299.90	13.57	14.10	20.09	2.82	2.82
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	186.61	22.60	14.34	11.38	3.12	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	176.20	20.96	17.71	14.20	2.30	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	74.81	8.82	4.94	6.00	1.41	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	211.32	22.81	19.89	13.45	4.39	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	214.48	29.18	12.68	15.41	1.50	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	211.16	23.69	16.12	12.83	2.41	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	431.85	31.55	28.47	25.83	3.82	1.61
Fibroblast - Lung, donor1	11270-116H1	32.62	6.80	2.72	1.36	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	95.50	13.43	8.95	7.46	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	57.61	11.61	4.01	2.11	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	95.80	12.50	5.00	5.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	64.34	8.39	1.40	4.20	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	27.15	3.64	1.68	0.84	0.28	0.56
Fibroblast - Mammary, donor1	11540-120B1	133.16	20.30	4.06	5.68	2.84	0.41
Fibroblast - Mammary, donor2	11620-122A9	31.95	0.00	3.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	101.26	17.87	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	96.21	25.02	5.24	5.63	1.55	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	99.05	20.17	4.85	2.12	1.97	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	259.48	28.15	11.32	14.69	4.28	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	171.73	22.13	9.92	13.36	2.29	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	294.83	18.90	14.85	17.28	2.70	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	272.89	20.41	16.35	17.86	2.20	1.51
Fibroblast - Pulmonary Artery, donor1	11250-116E8	142.48	16.47	7.63	7.85	1.77	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	105.66	13.61	9.75	8.13	1.63	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	23.39	6.68	2.67	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	95.28	6.72	5.54	5.14	2.77	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	109.15	6.95	12.90	11.51	0.60	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	224.33	20.96	14.39	16.16	0.71	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	266.85	26.61	15.18	17.34	2.56	2.17
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	162.46	14.74	16.85	15.95	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	227.56	22.67	16.08	16.95	3.02	1.73
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	152.60	5.06	16.70	13.16	0.25	0.76
Fibroblast - skin normal, donor1	11553-120C5	205.75	21.49	17.56	19.69	2.46	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	270.68	25.06	31.08	25.06	0.80	0.20
Fibroblast - skin normal, donor2	11561-120D4	183.14	24.31	12.26	10.95	1.91	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	98.53	5.74	7.56	12.39	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	286.73	27.92	18.14	22.12	2.57	1.16
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	294.38	28.55	15.56	17.44	3.42	2.56
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	156.01	16.09	14.78	13.79	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	130.92	15.98	11.61	9.69	2.24	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	133.76	14.68	10.29	10.29	1.69	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	133.77	13.17	15.05	12.86	2.51	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	44.32	22.16	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	32.25	20.05	7.84	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	109.04	12.31	9.19	10.40	1.21	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	149.90	14.83	11.97	12.23	1.82	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	116.51	8.43	10.73	9.71	1.02	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	36.75	24.50	3.83	0.77	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	43.39	23.61	3.19	5.10	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	56.48	23.68	3.14	3.99	0.57	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	51.57	11.58	7.17	10.20	1.38	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	60.96	7.76	9.36	4.11	0.68	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	44.58	18.23	4.36	3.57	0.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	48.90	10.04	8.72	11.10	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	31.96	5.54	12.39	7.18	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	49.09	16.80	3.98	4.42	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	57.09	17.24	3.39	5.23	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	55.54	13.18	5.05	6.28	0.99	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	63.93	15.04	6.18	4.84	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	64.67	17.22	4.46	4.09	0.74	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	62.85	20.63	5.26	5.26	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	69.73	15.86	3.66	5.69	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	66.40	17.57	3.19	4.11	0.91	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	64.65	13.45	4.11	4.36	1.62	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	82.40	17.27	3.72	5.03	1.53	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	78.01	15.96	5.02	6.50	2.07	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	64.85	16.69	3.66	4.45	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	73.51	15.86	2.23	6.93	2.46	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	66.14	13.31	4.03	5.04	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	66.84	13.23	4.07	5.09	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	124.50	23.50	7.27	9.49	1.86	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	97.19	24.56	4.27	6.14	0.83	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	94.10	21.86	4.61	7.34	0.85	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	60.86	12.95	5.20	7.30	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	113.90	19.38	7.65	8.90	2.16	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	102.29	22.87	5.92	8.58	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	67.26	13.41	2.89	5.36	1.24	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	68.48	14.99	3.57	3.34	0.58	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	71.04	11.01	4.84	6.84	0.33	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	66.57	12.34	3.97	4.41	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	77.12	13.28	4.18	5.17	1.60	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	68.57	8.92	5.84	8.10	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	79.54	15.07	3.21	3.21	1.60	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	64.05	9.29	4.36	4.83	0.66	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	67.07	11.23	3.80	4.90	0.63	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	69.03	13.68	3.34	2.13	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	65.96	10.56	4.60	5.02	1.05	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	78.16	10.54	4.83	6.81	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	72.10	10.10	6.45	3.37	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	67.31	7.04	4.81	5.74	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	72.20	7.75	5.88	3.21	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	66.10	8.11	5.20	3.98	0.92	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	64.38	7.51	6.22	7.51	0.91	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	95.96	10.57	6.78	7.86	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	90.70	12.17	7.37	4.42	2.21	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	84.44	11.62	6.58	6.58	2.19	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	82.31	10.91	11.90	6.94	1.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	88.25	10.55	6.86	7.26	1.58	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	100.68	10.49	6.86	8.27	1.82	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	215.02	19.82	11.69	18.05	2.54	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	58.32	28.47	5.97	5.77	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	48.23	23.42	4.01	3.54	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	47.46	25.98	4.71	7.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	45.69	20.34	5.63	3.76	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	42.95	25.43	3.67	3.39	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	47.04	29.98	4.61	2.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	7.42	12.37	12.37	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	66.53	17.41	7.35	6.19	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	80.22	22.46	6.42	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	46.95	12.17	6.96	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	70.30	17.90	6.18	8.14	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	68.77	19.35	4.53	6.18	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	6.66	13.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	68.79	21.81	5.59	6.43	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	66.35	19.28	4.58	5.23	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	34.39	15.94	4.19	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	73.47	22.27	3.18	5.09	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	69.29	23.44	5.09	4.42	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	52.20	25.06	6.26	8.35	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	65.86	24.05	2.86	4.01	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	46.17	18.94	2.07	6.22	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	64.38	8.47	5.08	11.86	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	77.87	14.50	7.46	9.94	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	65.36	14.73	5.98	8.05	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	26.34	0.00	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	74.96	19.22	5.77	5.77	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	73.34	17.28	7.50	6.85	3.26	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	52.17	11.37	5.35	6.02	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	91.31	21.19	2.31	5.01	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	97.91	19.17	9.59	14.72	2.05	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	29.82	0.00	14.91	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	77.86	22.65	1.89	6.13	4.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	97.77	24.14	9.05	7.85	2.41	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	76.30	19.84	4.58	5.60	3.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	69.40	25.92	5.58	8.77	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	77.95	26.64	4.44	6.41	0.99	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	96.80	31.87	3.54	7.08	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	78.18	28.01	3.50	5.83	2.33	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	125.08	27.21	1.32	6.14	5.71	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	58.49	17.80	6.78	1.70	0.85	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	54.32	9.55	2.98	6.57	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	65.51	6.79	6.79	7.28	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	79.89	12.55	6.85	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	93.97	7.48	6.24	4.57	0.42	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	50.60	5.62	4.50	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	314.31	13.96	11.10	22.52	8.56	5.07
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	211.80	8.77	4.18	8.77	6.27	4.18
Hep-2 cells mock treated, biol_rep1	11898-125E8	207.83	18.10	10.56	14.04	0.12	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	230.75	19.58	10.47	13.84	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	180.41	20.48	10.01	12.51	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	212.06	18.36	10.60	13.99	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	205.03	20.42	9.46	15.47	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	187.51	17.65	9.26	12.49	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	199.76	18.43	8.22	13.95	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	193.85	20.07	9.26	15.78	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	153.78	16.98	8.01	11.85	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	31.34	6.72	2.24	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	26.40	7.36	0.87	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	58.16	15.86	5.29	5.29	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	85.01	15.17	4.59	4.94	6.35	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	37.05	7.99	2.18	2.18	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	116.27	16.78	7.87	6.47	4.37	2.10
Hepatocyte, donor1	11523-119I2	146.48	30.27	20.58	12.11	2.42	1.21
Hepatocyte, donor2	11603-120I1	258.56	22.62	16.16	21.55	1.08	2.15
Hepatocyte, donor3	11684-122I1	187.13	32.52	14.11	12.27	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	142.94	18.28	36.55	27.41	1.96	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	316.35	13.46	20.10	28.66	2.45	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	158.20	13.72	7.55	11.39	2.20	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	2.77	1.38	2.77	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	2.50	2.50	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	5.13	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	9.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	12.99	9.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	5.00	1.67	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	1.32	5.29	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	32.15	6.65	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	22.05	3.78	1.89	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	1.55	6.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	25.84	1.29	0.00	2.58	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	0.00	6.44	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	19.56	4.89	0.81	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	15.11	2.94	2.52	1.68	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	22.50	2.41	0.80	1.61	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	16.62	0.92	1.85	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	28.32	2.36	0.47	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	14.51	3.63	0.91	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	0.00	14.74	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	17.22	5.38	4.30	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	1.27	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	13.39	1.91	0.64	1.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	3.65	3.65	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.85	2.14	1.43	1.43	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	25.62	3.40	3.09	1.54	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	15.80	3.51	1.76	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	3.14	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	19.47	0.70	2.78	2.78	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	2.21	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	24.41	1.74	4.36	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	2.25	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	21.34	3.20	0.00	3.20	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	6.93	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.05	4.60	2.76	2.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	3.03	6.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	24.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	5.29	3.17	2.11	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	83.88	6.04	4.73	4.16	0.49	0.08
Keratinocyte - epidermal, donor2	11349-117G8	30.45	4.10	1.17	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	85.85	14.67	5.02	3.60	2.56	0.28
Keratinocyte - oral, donor1	11251-116E9	115.79	18.28	4.88	5.68	0.45	0.11
Keratocytes, donor1	11527-119I6	56.39	5.50	5.50	3.78	1.03	1.72
Keratocytes, donor2	11607-120I5	38.67	4.69	3.52	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	117.37	8.30	6.72	5.93	1.19	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	63.74	4.40	6.59	10.99	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	66.88	10.79	1.08	3.24	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	79.23	13.26	10.96	7.27	0.69	0.12
Lens Epithelial Cells, donor3	11690-122I7	299.50	19.27	13.93	15.74	2.22	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	57.39	10.20	3.32	3.08	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	38.51	5.02	1.12	1.40	1.67	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	80.12	8.34	4.72	5.04	2.05	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	30.11	7.53	1.61	0.00	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	35.93	6.30	1.58	0.63	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	26.41	3.67	1.83	1.73	0.54	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	55.81	9.44	2.87	4.51	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	18.71	2.02	1.52	0.00	1.26	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	34.48	3.80	1.41	1.55	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	47.07	8.70	2.37	1.58	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	55.84	6.79	3.49	2.33	2.33	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.66	2.41	0.74	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	51.22	7.67	2.09	2.79	1.05	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	45.80	7.39	0.72	2.15	0.95	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	30.08	3.57	2.20	1.37	0.96	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	51.74	8.93	3.70	3.39	0.92	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	24.94	3.12	1.87	1.25	1.25	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	34.77	4.21	1.65	0.91	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	39.16	4.28	1.97	2.96	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.36	2.64	1.46	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	22.40	1.74	1.24	1.49	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	53.35	7.76	1.45	5.33	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	47.67	6.19	2.15	1.89	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	38.60	4.54	1.21	2.88	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	34.73	4.15	2.07	1.04	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	64.49	6.49	2.93	4.19	1.26	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	33.53	4.81	1.35	1.80	1.20	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	41.27	6.88	1.38	4.82	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	39.32	5.46	0.75	1.13	1.51	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.64	3.61	0.53	0.95	0.53	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	46.03	3.88	0.97	1.94	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	39.36	3.64	1.98	0.66	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	26.02	2.73	0.62	0.74	1.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	66.27	10.00	4.81	2.96	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	47.44	6.42	2.22	3.46	0.49	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	25.02	2.34	0.41	0.55	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	57.25	12.54	3.54	5.47	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	62.08	7.91	1.83	4.56	2.13	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	50.67	5.46	2.80	3.22	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	52.27	6.04	2.13	2.13	1.07	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	32.00	2.42	0.97	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	16.49	4.05	1.56	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	46.55	6.45	2.15	1.79	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	34.63	3.27	1.96	2.29	1.63	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	16.01	1.41	0.00	0.24	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	58.41	8.42	3.47	4.08	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	23.56	2.05	0.77	0.77	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	18.80	3.88	1.49	1.79	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	54.38	9.06	4.53	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	46.80	9.97	4.60	3.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	39.34	8.16	2.23	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	33.00	4.23	4.23	3.39	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	25.32	5.63	3.52	1.41	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.02	5.60	2.80	5.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	21.64	5.67	1.55	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	26.17	1.19	0.00	3.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	35.29	5.88	3.85	3.62	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	44.79	9.02	5.82	5.82	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	49.07	13.51	4.50	4.95	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	41.59	5.96	3.39	2.17	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	35.43	5.65	2.05	1.54	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	52.58	7.41	4.23	4.59	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	38.65	10.66	2.67	2.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	42.28	6.62	3.06	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	57.36	12.01	3.74	5.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	54.42	7.56	4.72	3.97	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	42.34	7.98	3.68	3.68	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	51.37	6.52	7.34	4.08	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	59.97	9.37	3.96	5.62	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	50.73	8.13	6.17	5.04	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	47.40	7.21	4.12	3.09	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	61.25	7.84	5.52	7.26	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	63.67	7.47	4.19	4.78	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	65.84	7.19	2.77	5.53	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	43.48	4.95	2.47	4.95	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	55.32	8.85	6.64	3.69	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	29.93	5.76	1.15	3.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	48.74	4.99	3.84	3.07	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	34.53	6.23	1.70	1.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	40.20	6.56	4.10	9.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	36.15	5.87	2.26	3.16	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	38.78	8.62	2.87	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	56.76	13.44	3.73	3.73	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	43.10	2.97	2.97	3.34	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	52.98	9.91	3.02	2.15	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	47.95	7.71	5.14	1.71	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	40.65	8.00	4.00	2.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	33.79	4.83	3.02	3.02	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	42.66	1.42	1.42	4.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	48.12	6.19	3.44	3.44	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	42.94	5.90	2.68	3.22	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	29.63	5.39	2.69	2.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	51.12	7.78	3.70	5.56	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	47.68	4.65	1.16	3.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	35.96	5.29	1.06	3.17	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	44.82	7.60	2.00	1.20	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	5.81	1.45	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	35.26	5.37	3.83	3.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	30.09	5.43	2.96	2.96	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	29.17	2.82	1.88	2.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	33.69	3.52	5.53	3.02	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	40.56	4.96	4.51	1.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	3.44	3.44	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	31.62	7.57	2.23	4.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	42.23	6.65	2.35	3.13	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.33	2.64	1.98	4.62	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	36.84	7.26	2.08	4.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	33.69	5.69	1.75	1.75	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	38.58	6.71	3.35	3.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	47.70	5.74	3.97	2.65	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	43.97	6.17	3.09	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	41.01	7.60	3.04	4.05	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	40.85	7.69	4.81	4.33	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	45.72	8.35	2.39	1.59	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	30.99	6.68	1.82	4.25	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	30.43	5.53	1.38	1.38	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	48.26	7.22	4.56	1.52	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	40.28	8.78	3.61	2.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	27.21	1.81	4.23	3.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	58.63	10.77	4.44	3.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	25.06	6.40	2.13	2.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	22.99	4.02	5.17	3.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	32.91	2.06	3.60	1.03	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	36.78	9.90	2.83	3.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	24.97	3.97	5.67	2.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	44.51	6.66	2.91	2.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	38.37	9.40	0.00	3.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.48	10.02	4.59	3.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	39.96	5.11	1.39	2.79	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	37.47	6.02	2.68	2.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	37.42	5.88	4.81	3.74	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	46.47	7.68	2.83	3.64	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.03	3.67	3.67	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	26.67	7.11	2.67	6.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	39.89	7.98	1.71	5.70	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	27.61	6.14	3.07	5.37	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	35.02	11.49	4.92	4.92	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	40.54	6.24	3.56	3.12	1.34	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	51.21	10.66	4.94	3.38	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	25.20	7.29	3.32	1.33	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	49.89	4.16	2.08	6.24	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	157.49	7.52	7.29	8.20	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	148.64	10.28	6.61	8.44	0.73	0.37
Macrophage - monocyte derived, donor3	11389-118C3	126.76	9.57	5.64	7.08	1.18	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	133.82	9.56	6.90	6.90	2.66	0.53
Mallassez-derived cells, donor2	11929-125I3	198.86	17.11	16.00	20.28	4.12	0.95
Mallassez-derived cells, donor3	11930-125I4	129.81	12.79	9.59	9.73	1.39	0.69
Mammary Epithelial Cell, donor1	11273-116H4	131.73	8.07	13.65	10.06	1.79	0.60
Mammary Epithelial Cell, donor2	11350-117G9	81.65	5.79	8.11	5.21	1.16	0.58
Mammary Epithelial Cell, donor3	11422-118F9	37.16	2.99	3.49	2.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	324.05	17.63	9.49	6.78	4.07	1.36
Mast cell, donor1	11563-120D6	122.09	14.71	3.57	3.24	1.51	0.87
Mast cell, donor2	11565-120D8	176.82	22.88	4.46	5.05	2.67	1.49
Mast cell, donor3	11566-120D9	167.49	31.29	3.38	4.05	4.28	0.68
Mast cell, donor4	11567-120E1	154.06	29.96	3.72	4.96	3.72	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	206.15	19.41	6.21	7.98	2.33	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	166.93	15.18	4.67	4.09	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	104.17	11.70	2.75	3.67	1.03	0.11
Mast cell, expanded, donor8	11941-126A6	97.74	7.70	2.51	3.68	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	118.40	21.09	7.06	7.26	3.08	0.40
Melanocyte - dark, donor2	11582-120F7	83.75	15.23	4.50	3.46	1.73	0.00
Melanocyte - dark, donor3	11663-122F7	132.57	17.17	7.75	7.17	0.80	0.14
Melanocyte - light, donor1	11274-116H5	36.91	4.70	2.12	1.88	0.47	0.00
Melanocyte - light, donor2	11351-117H1	30.03	2.73	0.68	2.05	0.00	0.00
Melanocyte - light, donor3	11423-118G1	48.56	0.87	1.73	3.47	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	104.13	13.43	5.83	6.25	0.52	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	134.74	13.18	6.45	7.26	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	84.91	9.37	6.70	6.43	1.61	0.00
Meningeal Cells, donor1	11493-119E8	75.68	16.00	6.70	4.47	1.49	0.37
Meningeal Cells, donor2	11573-120E7	89.35	7.04	12.76	5.72	1.76	1.32
Meningeal Cells, donor3	11654-122E7	117.12	19.72	7.82	5.05	1.30	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	230.98	13.69	8.27	11.98	1.43	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	193.92	16.10	6.74	10.87	1.91	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	28.91	1.31	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	3.92	0.00	2.62	3.92	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	113.38	17.22	5.74	2.87	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	177.25	19.69	15.04	14.61	1.06	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	136.72	10.56	15.58	13.57	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	78.23	11.65	2.64	3.08	0.44	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	46.03	4.38	1.46	2.19	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	46.44	5.73	1.84	1.84	0.82	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	529.51	19.25	16.62	36.15	5.12	4.85
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	51.30	2.60	4.09	2.97	0.74	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	481.04	26.97	21.84	28.81	7.76	4.21
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	40.06	3.86	2.67	2.37	1.48	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	2.34	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	74.29	8.33	0.00	3.84	0.64	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	151.35	18.43	4.61	3.54	1.06	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	422.49	20.64	16.26	24.08	4.38	3.44
Mesenchymal stem cells - umbilical, donor0	11214-116A8	97.97	13.79	4.35	6.53	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	157.51	16.18	7.16	8.49	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	123.62	11.51	7.51	10.51	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	125.96	16.91	10.84	8.45	0.94	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	126.93	18.90	4.05	5.40	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	140.87	10.59	9.11	8.37	1.48	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	119.84	9.72	5.30	8.24	0.88	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	100.26	10.37	0.00	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	117.78	8.99	8.06	6.82	1.24	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	105.17	6.02	5.39	4.15	0.83	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	69.48	13.90	4.63	6.95	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	126.38	7.26	6.26	6.51	1.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	109.39	7.91	5.59	4.65	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	19.47	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	124.16	6.30	5.49	6.10	1.02	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	103.35	8.32	4.36	5.15	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	89.38	4.42	5.31	3.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	109.04	6.46	4.56	4.94	1.52	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	92.11	9.21	3.95	5.26	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	90.83	5.73	5.31	5.52	1.70	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	63.54	7.37	1.84	3.68	3.68	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	83.46	5.07	5.66	3.58	1.79	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	38.56	5.03	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	95.84	5.27	4.27	6.02	1.00	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	105.52	6.89	2.85	1.90	1.19	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	102.28	10.50	2.76	4.98	0.55	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	100.39	5.30	4.37	4.37	2.53	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	90.66	6.94	4.84	4.21	1.47	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	90.91	6.52	4.08	5.91	0.82	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	102.98	6.87	4.51	4.08	1.29	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	100.92	6.45	6.45	5.56	1.33	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	92.87	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	90.89	6.35	5.48	4.38	1.53	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	98.35	5.07	0.51	1.52	2.53	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	96.11	13.26	3.31	0.00	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	90.51	5.16	5.71	5.44	1.63	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	108.52	5.00	5.29	4.71	1.47	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	88.32	8.72	3.27	6.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	87.46	7.69	3.36	4.81	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	106.46	7.20	2.80	6.80	1.20	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	83.64	10.97	12.34	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	111.13	9.01	7.01	7.01	1.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	188.63	53.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	61.16	6.12	0.00	4.08	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	122.62	10.51	8.32	6.57	2.19	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	75.05	7.73	3.31	6.62	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	76.85	9.61	3.20	2.56	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	113.79	9.92	3.22	5.70	0.74	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	87.68	12.53	5.57	2.78	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	79.56	13.26	4.42	4.42	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	118.29	10.94	2.05	6.15	2.05	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	75.27	7.88	3.94	4.81	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	56.46	6.39	2.49	3.20	0.71	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	115.03	8.70	6.45	5.61	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	115.13	6.23	7.07	5.82	0.83	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	64.10	7.58	5.24	4.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	90.80	8.75	5.13	5.13	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	122.71	6.68	5.01	8.35	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	79.41	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	100.67	15.70	1.85	5.54	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	105.29	7.97	3.41	6.83	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	74.34	6.36	4.01	4.70	0.41	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	98.99	8.29	6.48	5.96	1.04	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	96.09	6.43	7.29	5.58	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	62.88	15.24	3.81	1.91	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	83.54	5.60	4.80	4.54	0.80	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	127.51	8.08	7.48	7.18	2.10	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	62.01	4.80	1.41	3.96	0.28	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	99.69	7.64	3.19	5.10	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	126.49	5.75	5.53	6.41	1.11	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	78.12	9.48	4.17	5.69	1.52	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	86.94	9.09	5.40	5.97	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	141.34	5.90	6.15	6.15	1.47	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	72.34	8.47	3.26	0.00	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	93.50	8.53	6.17	6.76	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	128.31	5.77	8.36	6.63	1.15	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	125.29	9.48	5.77	5.36	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	93.50	6.55	5.66	6.55	0.89	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	109.24	3.77	7.53	11.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	99.81	7.13	7.13	8.91	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	132.74	8.54	5.59	7.56	1.97	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	115.71	8.42	8.42	6.31	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	151.03	13.84	12.06	9.69	1.78	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	122.00	13.04	13.97	8.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	94.26	7.89	11.64	7.51	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	101.21	6.66	5.59	7.46	0.80	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	143.53	9.50	9.05	9.95	0.90	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	77.36	8.10	5.16	4.42	2.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	115.42	6.96	7.33	6.96	2.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	110.45	1.56	12.44	9.33	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	194.54	14.43	12.29	14.43	2.67	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	7.73	3.86	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	105.03	7.07	2.02	11.11	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	118.06	10.12	10.12	8.43	1.69	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	213.82	24.51	12.26	10.90	5.45	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	167.85	15.26	15.89	6.36	4.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	272.11	24.30	10.53	13.77	2.43	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	137.45	7.55	6.04	7.55	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	0.00	5.71	5.71	0.00	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	107.66	9.79	3.26	13.05	16.31	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	104.55	23.76	0.00	4.75	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	191.74	12.50	9.48	14.22	3.23	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	191.80	10.45	12.54	19.86	3.66	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	44.72	9.34	4.67	2.67	2.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	68.45	5.01	9.60	8.35	5.43	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	77.39	6.65	5.70	6.85	2.47	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	79.79	11.17	4.79	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	30.60	4.76	7.48	2.72	3.40	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	77.18	7.35	11.03	5.51	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	33.90	9.21	1.67	5.44	0.84	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	81.35	4.42	17.20	10.46	5.11	1.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	42.70	7.57	8.92	5.67	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	65.38	12.40	6.94	5.47	1.47	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	167.02	11.13	11.13	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	57.58	7.45	9.43	4.47	2.48	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	87.43	8.39	7.04	8.12	1.89	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	85.69	8.84	12.47	10.20	5.67	2.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	66.46	5.39	9.31	7.35	1.80	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	96.60	10.57	6.56	8.38	0.73	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	68.96	7.43	8.49	5.83	3.18	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	64.23	7.80	9.00	4.20	2.40	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	125.04	6.56	8.20	9.52	3.28	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	109.61	7.97	16.75	12.03	6.99	2.76
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	96.66	10.76	5.12	7.41	1.06	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	79.47	9.14	11.25	4.92	4.22	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	81.37	10.11	10.57	7.36	4.60	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	83.23	7.07	8.68	6.75	2.57	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	246.94	7.59	16.21	34.83	12.07	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	212.39	7.59	5.06	2.53	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	104.04	9.36	10.69	9.58	1.78	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	80.87	8.04	8.04	8.47	6.35	2.96
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	124.61	11.63	9.26	9.26	4.51	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	88.43	12.88	10.30	12.45	2.15	3.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	352.08	18.06	36.11	27.08	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	99.97	7.66	14.33	9.33	0.67	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	99.19	16.68	8.57	9.02	1.35	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	57.93	8.73	4.76	7.54	4.36	2.78
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	73.36	12.07	8.36	9.29	3.71	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	155.89	6.43	17.78	20.81	4.16	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	124.81	10.75	16.95	14.99	8.80	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	90.64	7.84	10.46	7.41	1.74	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	125.74	12.66	7.69	7.24	3.17	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	57.32	17.64	14.11	3.53	4.41	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	83.77	9.97	9.97	11.97	3.32	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	88.79	11.41	12.90	12.90	3.97	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	116.38	11.10	13.40	12.25	6.89	6.89
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	201.73	10.59	13.31	17.84	0.91	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	135.71	13.26	8.18	13.48	0.00	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	74.54	7.45	8.81	6.10	4.74	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	158.40	10.22	10.22	20.44	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	106.08	8.54	8.54	16.46	4.88	4.27
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	158.31	12.27	14.48	11.02	10.07	6.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	88.98	11.50	6.96	5.45	1.51	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	94.94	9.49	13.45	12.66	2.37	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	208.59	12.47	14.74	21.54	6.80	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	151.74	5.06	20.23	35.41	5.06	0.00
Myoblast, donor1	11241-116D8	227.34	14.16	9.44	15.28	1.61	0.99
Myoblast, donor2	11322-117D8	277.13	11.12	14.58	13.23	1.73	1.92
Myoblast, donor3	11398-118D3	181.28	17.99	11.27	11.27	2.19	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	221.82	29.19	33.13	31.38	4.09	0.58
Natural Killer Cells, donor1	11230-116C6	257.70	13.53	4.61	5.84	4.92	1.23
Natural Killer Cells, donor2	11311-117C6	193.00	12.06	3.62	8.44	3.92	0.90
Natural Killer Cells, donor3	11387-118C1	194.91	11.23	4.97	6.26	2.94	1.10
Neural stem cells, donor1	11275-116H6	75.13	15.61	13.07	9.80	1.45	0.00
Neural stem cells, donor2	11352-117H2	61.62	23.11	13.48	9.63	0.00	0.00
Neurons, donor1	11494-119E9	37.55	12.52	4.55	6.83	0.00	0.00
Neurons, donor2	11574-120E8	42.93	11.89	4.40	4.84	0.44	0.00
Neurons, donor3	11655-122E8	32.89	7.40	5.76	4.93	1.64	0.00
Neutrophils, donor1	11233-116C9	117.86	2.78	9.28	14.85	0.93	0.00
Neutrophils, donor2	11314-117C9	57.98	0.00	5.80	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	147.82	5.50	11.61	6.11	5.50	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	751.12	27.31	23.51	37.40	4.51	3.09
Nucleus Pulposus Cell, donor2	11409-118E5	245.18	11.72	9.77	12.70	2.28	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	153.02	8.42	11.63	12.63	0.80	0.80
Olfactory epithelial cells, donor1	11933-125I7	187.34	17.34	17.62	19.13	3.44	1.51
Olfactory epithelial cells, donor2	11934-125I8	214.66	15.49	24.61	20.12	3.62	1.45
Olfactory epithelial cells, donor3	11935-125I9	272.18	14.87	23.27	22.81	3.75	2.16
Olfactory epithelial cells, donor4	11936-126A1	281.19	28.15	15.78	18.99	3.12	1.75
Oligodendrocyte - precursors, donor1	11496-119F2	816.07	31.90	16.25	58.98	4.21	1.20
Osteoblast - differentiated, donor1	11276-116H7	180.79	16.38	5.96	9.15	1.91	1.70
Osteoblast - differentiated, donor2	11353-117H3	110.88	3.43	6.86	10.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	130.35	6.83	8.69	3.10	2.48	1.24
Osteoblast, donor1	11277-116H8	33.03	5.47	2.35	1.76	0.20	0.39
Osteoblast, donor2	11354-117H4	128.52	17.56	10.53	7.02	0.70	0.00
Osteoblast, donor3	11426-118G4	135.61	12.26	9.42	9.06	1.78	1.07
Pancreatic stromal cells, donor1	11249-116E7	163.92	17.10	13.90	10.36	2.36	0.51
Pericytes, donor1	11491-119E6	11.79	3.56	0.56	0.78	0.11	0.00
Pericytes, donor2	11571-120E5	19.47	2.26	2.72	1.36	0.45	0.00
Pericytes, donor3	11652-122E5	101.93	8.34	4.07	7.12	1.63	0.61
Perineurial Cells, donor1	11499-119F5	190.33	16.28	13.00	14.35	1.92	0.34
Perineurial Cells, donor2	11579-120F4	136.08	20.24	8.28	6.81	2.39	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	225.67	12.75	8.61	12.43	1.27	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	110.68	6.12	5.14	6.12	1.22	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	138.86	8.67	7.12	6.86	1.42	0.65
Placental Epithelial Cells, donor1	11278-116H9	28.94	4.07	2.63	2.39	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	43.25	7.76	9.98	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	33.57	4.91	2.75	2.55	1.18	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	173.73	20.25	10.76	11.08	2.22	0.63
Preadipocyte - breast, donor1	11467-119B9	256.62	20.63	14.07	18.01	1.50	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	216.28	13.05	13.84	13.18	0.65	0.13
Preadipocyte - breast, donor2	11328-117E5	209.16	13.06	10.13	18.01	1.13	0.68
Preadipocyte - omental, donor1	11468-119C1	266.61	24.51	13.00	20.67	0.64	0.53
Preadipocyte - omental, donor2	11329-117E6	353.54	26.19	20.08	24.44	2.18	1.31
Preadipocyte - omental, donor3	11403-118D8	266.01	19.77	12.03	17.48	1.00	0.86
Preadipocyte - perirenal, donor1	11469-119C2	84.65	2.95	10.83	1.97	0.98	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	87.84	8.60	4.30	4.30	1.23	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	126.43	17.88	6.55	4.25	4.78	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	143.55	12.43	9.37	6.13	1.87	1.36
Preadipocyte - visceral, donor1	11280-116I2	126.03	20.77	6.52	6.15	1.96	0.93
Preadipocyte - visceral, donor2	11357-117H7	118.73	12.89	10.58	5.52	2.76	0.46
Preadipocyte - visceral, donor3	11429-118G7	76.07	12.33	4.70	3.03	0.94	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	163.37	7.69	17.50	22.48	1.36	0.91
Prostate Epithelial Cells, donor2	11331-117E8	380.78	7.85	17.74	30.06	4.87	2.57
Prostate Epithelial Cells, donor3	11404-118D9	94.86	11.02	3.74	4.41	0.86	0.06
Prostate Stromal Cells, donor1	11254-116F3	319.04	17.77	18.45	21.19	7.97	2.62
Prostate Stromal Cells, donor2	11332-117E9	252.27	11.83	13.27	15.42	3.41	1.43
Prostate Stromal Cells, donor3	11405-118E1	376.54	15.85	21.90	22.73	11.78	4.48
Renal Cortical Epithelial Cells, donor1	11516-119H4	39.78	8.39	2.19	1.82	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	136.20	16.01	7.21	8.39	0.83	0.55
Renal Epithelial Cells, donor1	11517-119H5	29.93	11.16	2.54	0.00	1.52	0.00
Renal Epithelial Cells, donor2	11597-120H4	20.63	2.13	1.42	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	160.49	22.76	8.89	9.21	1.38	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	27.91	4.77	1.36	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	33.15	6.60	2.70	2.16	1.48	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	110.34	19.54	4.66	7.77	2.00	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	19.30	2.66	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	51.72	6.16	1.98	3.74	0.66	0.44
Renal Mesangial Cells, donor2	11598-120H5	38.25	6.90	3.76	4.39	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	26.08	2.50	0.00	3.05	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	106.03	17.98	6.17	6.71	1.34	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	41.33	10.54	2.11	3.37	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	36.06	6.56	2.70	2.31	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	66.64	14.78	2.59	3.63	0.78	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	39.79	7.11	1.14	1.42	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	4.12	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	96.85	9.53	5.27	5.52	1.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	200.59	26.46	22.45	17.91	2.94	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	41.99	3.57	7.15	6.25	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	31.37	4.95	4.95	4.95	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	34.22	3.48	2.32	5.22	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	57.60	5.07	7.93	7.02	0.26	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	45.58	4.57	5.76	5.46	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	67.04	4.68	7.70	6.69	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	61.77	4.22	8.06	7.19	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	48.25	3.50	6.18	4.43	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	53.85	3.47	4.62	8.09	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	35.05	2.88	4.65	4.79	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	41.30	3.78	3.78	3.93	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	59.13	5.73	6.45	7.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	42.75	2.58	4.45	6.31	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	45.18	5.26	5.58	5.58	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	40.93	2.66	5.53	5.09	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	33.26	2.49	2.10	3.44	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	42.58	4.19	4.75	4.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	69.53	7.33	5.07	9.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	41.80	2.92	8.10	4.51	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	39.23	4.58	5.16	5.55	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	54.23	3.25	4.96	4.77	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	39.62	2.99	5.34	6.30	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	40.92	4.20	5.61	4.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	49.56	4.79	4.61	7.18	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.74	2.19	7.29	3.46	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	41.57	3.56	3.92	4.05	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	47.82	3.09	7.25	4.97	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	43.40	3.54	5.90	5.66	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	43.65	5.56	6.94	4.17	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	49.34	4.44	4.68	5.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	42.09	3.32	4.98	4.77	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	43.58	3.98	5.53	4.42	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	47.00	3.55	8.36	4.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	52.89	4.17	6.46	5.11	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	35.59	2.72	7.83	4.26	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	47.43	4.43	3.28	5.98	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	44.02	4.13	5.16	5.67	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	42.52	5.90	4.80	3.98	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	48.59	6.57	4.10	5.42	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	36.47	3.41	3.58	2.39	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	48.68	5.33	5.03	5.18	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	34.92	6.40	2.13	4.00	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	40.93	2.63	5.53	4.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	42.86	3.57	4.76	5.00	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	60.46	5.64	5.24	5.44	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	45.67	2.35	6.03	4.99	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	55.20	4.19	3.49	7.69	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	55.31	4.23	6.65	5.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	51.40	2.33	6.98	6.85	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	92.28	6.84	8.01	12.23	0.44	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	58.41	3.65	7.91	3.65	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	46.11	1.81	6.33	7.23	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	78.49	3.17	7.01	9.05	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	72.49	3.89	5.99	7.79	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	76.87	4.49	9.21	10.74	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	81.32	4.27	9.18	9.82	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	78.13	2.40	6.61	10.22	0.60	0.00
Schwann Cells, donor1	11498-119F4	25.01	2.63	2.44	1.50	0.56	0.56
Schwann Cells, donor2	11578-120F3	40.83	13.61	3.40	6.80	6.80	0.00
Schwann Cells, donor3	11659-122F3	82.16	7.89	6.13	5.70	1.31	0.00
Sebocyte, donor1	11220-116B5	94.22	8.22	5.48	8.22	0.55	0.55
Sebocyte, donor2	11301-117B5	56.07	3.22	3.22	3.22	0.46	0.00
Sebocyte, donor3	11378-118B1	56.47	5.77	3.71	2.89	0.00	0.00
Sertoli Cells, donor1	11255-116F4	273.34	28.16	33.13	19.88	3.31	0.00
Sertoli Cells, donor2	11333-117F1	203.35	11.30	8.47	11.30	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	42.49	6.77	4.05	3.34	0.44	0.00
Skeletal Muscle Cells, donor2	11358-117H8	32.53	5.06	2.89	0.72	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	36.79	4.18	2.51	3.34	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	89.07	14.77	4.56	3.14	1.57	0.79
Skeletal Muscle Cells, donor5	11455-119A6	82.05	14.72	2.53	3.57	2.68	0.74
Skeletal Muscle Cells, donor6	11459-119B1	83.11	14.77	3.23	3.54	2.31	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	208.54	23.82	8.57	9.70	4.66	2.14
Skeletal Muscle Satellite Cells, donor2	11321-117D7	184.07	14.55	6.85	9.85	2.43	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	114.98	20.54	3.87	3.27	1.49	1.39
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	94.19	8.43	7.67	6.15	1.01	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.09	4.34	1.45	2.17	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	33.71	4.40	3.30	1.51	1.38	0.14
Skin - palm, donor1	10286-104F7	45.66	67.15	2.69	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	152.52	6.05	7.78	8.51	1.15	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	148.86	9.81	7.36	11.45	1.64	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	95.94	5.32	8.57	4.80	2.99	1.30
Small Airway Epithelial Cells, donor1	11256-116F5	367.12	11.95	19.18	31.55	8.34	4.59
Small Airway Epithelial Cells, donor2	11334-117F2	321.40	11.39	16.74	27.43	7.88	4.78
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	288.83	10.57	19.88	24.74	4.02	2.33
Small Airway Epithelial Cells, donor3	11406-118E2	179.06	9.37	9.07	10.57	6.15	4.27
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	71.59	7.41	1.54	1.85	1.23	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	297.48	14.90	19.79	23.12	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	108.16	18.22	6.47	2.35	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	92.37	7.96	5.08	4.20	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	51.98	7.09	3.54	1.58	1.58	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	116.66	25.49	2.32	4.64	3.86	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	100.08	9.01	5.00	13.01	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	95.42	13.04	5.59	3.99	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	177.99	17.07	10.20	11.53	2.22	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	145.57	17.41	7.94	10.37	1.66	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	135.45	12.70	9.44	9.44	1.95	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	271.99	17.72	13.29	18.61	3.84	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	257.39	12.81	8.97	15.94	2.85	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	55.80	6.83	1.79	1.46	0.65	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	126.95	16.44	7.92	7.31	1.22	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	80.57	13.64	5.81	6.06	1.52	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	361.12	6.12	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	56.74	3.81	4.29	1.91	3.34	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	289.49	17.55	15.04	18.29	3.24	1.62
Smooth Muscle Cells - Colonic, donor2	11320-117D6	169.39	12.05	7.53	8.39	1.08	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	170.35	15.85	10.18	10.39	1.68	1.15
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	54.29	8.66	2.63	2.63	0.77	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	88.39	8.62	6.47	4.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	60.97	7.17	4.18	1.79	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	50.87	3.76	1.71	1.71	2.05	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	307.99	17.43	12.88	21.05	11.39	2.28
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	211.55	35.53	9.66	10.47	1.41	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	194.56	15.47	8.42	7.05	2.05	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	60.98	7.25	3.02	2.42	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	196.57	33.12	10.86	9.27	1.85	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	313.19	21.44	28.90	28.23	3.20	3.06
Smooth Muscle Cells - Prostate, donor2	11335-117F3	304.53	11.90	16.53	20.04	3.26	2.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	154.23	16.74	11.41	9.39	1.52	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	109.61	18.85	8.29	6.03	1.81	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	63.76	9.00	2.25	4.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	122.76	3.88	7.75	3.88	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	100.46	14.88	4.19	5.58	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	120.67	10.60	7.07	3.53	2.52	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	123.16	10.66	9.09	5.95	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	63.72	5.01	0.59	2.06	1.18	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	158.78	28.82	9.66	6.75	4.33	1.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	146.22	9.34	7.47	6.07	5.61	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	79.44	10.65	3.31	4.46	2.73	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	56.35	6.88	2.04	3.06	1.02	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	30.09	3.57	2.63	2.44	0.38	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	169.93	22.92	8.80	7.83	2.10	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	301.05	21.37	13.66	18.52	3.69	1.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	22.86	3.33	0.95	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	81.96	9.30	3.67	3.91	1.96	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	214.54	15.25	16.13	15.69	3.54	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	87.48	14.63	9.36	3.22	1.76	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	131.97	17.88	6.61	11.47	1.94	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	141.75	9.26	11.64	14.81	1.06	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	91.87	17.48	4.09	7.81	1.49	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	248.30	28.03	11.86	13.30	3.23	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	121.23	12.49	7.38	11.36	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	76.41	15.36	5.91	5.12	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	106.91	11.94	5.33	5.33	1.78	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	104.62	20.37	2.80	6.79	3.99	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	112.44	13.79	7.94	7.11	2.51	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	129.72	18.33	7.79	10.08	2.75	0.46
Synoviocyte, donor1	11291-117A4	249.11	14.81	12.96	18.68	2.86	1.51
Synoviocyte, donor2	11368-117I9	188.58	11.06	13.41	13.58	1.68	0.67
Synoviocyte, donor3	11440-118H9	127.34	9.83	12.29	12.73	2.90	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	30.73	9.65	2.50	2.86	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	61.44	1.98	5.95	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	33.11	2.55	2.08	2.55	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	74.70	11.18	2.94	2.87	1.22	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	43.30	6.96	0.39	0.77	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	25.77	3.44	1.72	2.29	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	204.22	26.82	23.50	19.81	1.23	0.49
Urethra, donor2	10319-105A4	75.53	16.19	1.80	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	136.28	6.38	2.66	9.03	1.06	0.27
Urothelial Cells, donor2	11600-120H7	48.07	2.80	2.00	2.80	0.80	0.40
Urothelial Cells, donor3	11681-122H7	69.22	3.90	0.92	4.13	0.23	1.15
Urothelial cells, donor0	11216-116B1	657.99	23.85	12.48	29.42	6.91	7.58
Whole blood (ribopure), donor090309, donation1	12179-129A1	145.92	13.35	28.47	23.13	2.67	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	171.55	17.16	12.87	15.73	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	101.31	7.53	6.85	6.16	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	140.49	12.40	8.95	14.46	2.41	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	138.87	8.72	11.62	5.81	4.65	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	153.06	7.29	13.54	24.99	4.16	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	164.28	10.10	18.36	12.85	9.18	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	106.81	4.56	6.39	9.13	5.48	0.00
Wilms' tumor cell line:G-401	10809-111A8	51.69	11.72	5.18	4.07	0.86	0.25
Wilms' tumor cell line:HFWT	10597-108E3	41.36	11.44	4.40	3.52	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	35.47	5.59	4.75	1.40	1.12	0.56
achilles tendon, donor2	10292-104G4	70.26	6.20	6.20	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	84.65	6.88	8.16	8.67	1.53	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	94.73	22.29	17.65	15.79	3.02	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	121.32	7.24	19.71	14.01	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	108.57	21.50	6.80	5.44	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	211.94	35.98	7.87	8.15	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	103.41	7.61	4.65	3.38	0.21	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	173.13	10.89	10.34	7.89	1.63	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	85.04	14.54	3.08	3.08	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	87.80	13.88	6.13	6.94	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	116.49	15.14	12.43	12.04	0.39	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	36.25	5.89	1.29	1.66	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	74.11	3.90	15.60	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	85.75	10.69	8.83	9.99	0.46	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	127.38	12.43	6.73	8.28	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	111.34	14.03	5.26	3.51	0.88	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	98.06	25.56	8.37	7.90	4.18	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	109.80	9.87	7.81	5.76	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	87.48	24.86	4.91	5.83	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	92.60	22.62	6.83	5.55	2.56	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	120.41	24.87	7.89	6.37	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	121.32	30.09	4.81	4.81	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	64.15	9.80	4.01	1.56	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	46.70	10.01	0.67	1.33	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	44.60	26.01	0.00	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	112.24	19.59	4.52	7.53	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	68.04	8.72	2.62	6.54	0.00	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	61.86	24.37	5.62	5.62	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	95.14	4.71	22.61	17.66	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	138.21	17.99	6.98	8.53	0.93	0.31
adipose, donor1	10184-103D4	86.79	23.46	11.14	8.21	1.76	0.00
adipose, donor2	10185-103D5	30.82	10.14	3.65	6.08	0.81	0.00
adipose, donor3	10186-103D6	55.82	11.16	7.08	4.36	0.54	0.27
adipose, donor4	10187-103D7	161.22	15.60	4.33	1.73	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	45.93	17.04	2.68	1.10	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	47.29	3.64	7.28	3.64	7.28	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	78.44	6.80	5.87	5.47	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	57.88	6.79	13.58	9.29	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	102.71	17.16	26.20	13.91	0.70	0.70
amniotic membrane cells, donor2	12236-129G4	94.33	15.55	9.47	7.10	1.69	0.34
amniotic membrane cells, donor3	12237-129G5	60.69	18.85	7.07	3.24	0.29	0.29
amygdala - adult, donor10196	10167-103B5	21.34	8.30	1.19	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	60.02	11.15	3.65	3.04	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	32.92	10.01	1.29	2.90	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	155.09	14.01	10.95	18.21	1.78	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	78.98	5.07	6.62	5.52	0.00	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	65.14	5.01	9.35	7.35	0.33	0.00
aorta, adult, pool1	10052-101G7	81.20	12.55	9.81	3.14	1.37	0.59
appendix, adult	10189-103D9	107.12	17.08	13.58	8.93	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	51.93	11.69	7.22	7.22	0.69	0.34
artery, adult	10190-103E1	62.50	6.79	10.87	5.43	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	339.86	38.68	39.98	31.15	1.74	0.29
b cell line:RPMI1788	10427-106D4	134.13	22.90	3.87	5.65	8.77	2.83
basal cell carcinoma cell line:TE 354.T	10702-109G9	282.44	26.36	15.26	18.59	2.77	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	133.96	7.94	9.63	9.13	0.69	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	68.46	4.18	11.38	13.06	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	69.35	5.03	5.03	5.59	0.56	0.00
bladder, adult, pool1	10011-101C2	121.68	16.08	6.84	5.87	1.52	0.11
blood, adult, pool1	10053-101G8	75.30	2.21	13.29	6.64	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	202.95	30.83	11.99	17.98	3.43	0.00
bone marrow, adult	10192-103E3	100.55	9.45	9.45	7.42	0.67	0.00
brain, adult, donor1	10084-102B3	26.65	11.28	3.08	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	48.00	9.69	3.01	3.23	0.45	0.00
brain, fetal, pool1	10085-102B4	26.71	8.01	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	34.69	9.91	8.59	2.97	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	101.73	35.70	22.09	21.34	1.50	0.62
breast, adult, donor1	10080-102A8	87.76	16.42	10.73	8.21	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	69.49	15.12	10.16	7.62	1.14	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	62.15	14.84	19.17	10.20	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	42.82	8.98	7.14	5.30	0.23	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.49	3.63	2.42	0.48	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	26.33	5.17	3.29	1.88	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	145.80	17.39	17.06	15.42	2.73	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	51.65	6.65	3.17	0.95	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	78.79	16.77	10.11	5.86	1.33	0.00
caudate nucleus - adult, donor10196	10177-103C6	44.90	17.27	2.30	2.30	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	50.20	10.37	3.18	4.18	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	28.27	12.99	4.58	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	29.66	8.06	2.20	1.83	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	52.44	8.74	0.00	14.57	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	70.03	12.17	4.48	4.91	0.21	0.00
cerebellum, adult, pool1	10083-102B2	26.91	6.21	1.03	0.69	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	52.31	24.91	3.32	2.49	1.66	0.00
cerebral meninges, adult	10188-103D8	48.92	13.62	3.78	2.02	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	37.28	13.16	4.39	3.65	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	205.18	36.95	13.95	13.23	0.43	0.00
cervical cancer cell line:ME-180	10553-107I4	98.44	6.46	19.55	18.06	0.99	0.00
cervix, adult, pool1	10013-101C4	148.04	29.19	13.65	7.87	1.99	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	164.98	19.65	16.02	14.91	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	39.19	10.45	2.61	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	116.32	8.20	9.57	10.81	1.37	0.50
choriocarcinoma cell line:SCH	10785-110H2	83.17	15.77	6.53	4.68	0.99	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	39.85	7.59	2.37	3.32	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	153.29	10.83	29.35	11.97	1.42	0.28
chorionic membrane cells, donor2	12239-129G7	224.81	18.89	21.48	18.89	1.79	0.40
chorionic membrane cells, donor3	12240-129G8	184.08	5.49	36.82	15.94	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	82.80	14.14	17.17	20.20	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	184.99	19.02	14.02	14.22	0.77	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	68.64	13.73	6.34	3.17	0.84	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	42.37	12.33	2.31	1.03	0.77	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	53.21	12.34	3.63	2.90	0.97	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	53.35	11.40	4.28	3.26	1.43	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	43.58	13.25	6.77	4.71	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	194.69	38.57	5.73	5.21	0.26	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	137.61	22.17	9.60	10.74	1.37	0.46
clear cell carcinoma cell line:TEN	10636-108I6	184.96	21.17	16.48	23.08	1.39	0.69
colon carcinoma cell line:CACO-2	10513-107D9	255.89	10.25	39.72	35.33	3.66	1.83
colon carcinoma cell line:COLO-320	10420-106C6	113.64	18.24	13.30	12.16	4.56	0.38
colon, adult, donor1	10082-102B1	45.22	9.52	3.57	3.57	2.38	0.00
colon, adult, pool1	10014-101C5	148.99	15.86	19.27	17.51	0.82	0.35
colon, fetal, donor1	10070-101I7	49.44	16.69	14.83	4.33	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	499.60	77.92	13.75	13.75	13.75	4.58
common myeloid progenitor CMP, donor2	12134-128E1	125.18	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	200.14	16.57	11.05	9.77	1.27	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	143.69	18.26	5.28	4.53	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	138.90	17.20	6.91	6.20	0.56	0.28
corpus callosum, adult, pool1	10042-101F6	97.63	19.35	5.42	6.41	0.33	0.11
cruciate ligament, donor2	10295-104G7	94.83	19.45	3.24	3.24	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	48.96	18.46	9.63	5.62	0.80	0.00
diencephalon, adult	10193-103E4	35.28	9.60	2.16	3.84	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	55.80	2.30	4.13	5.97	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	111.04	16.67	13.08	15.13	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	56.09	7.22	5.30	4.09	0.72	0.24
ductus deferens, adult	10196-103E7	147.01	16.45	20.43	11.96	3.49	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	67.69	17.28	14.40	5.76	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	113.29	17.66	14.71	7.36	0.74	0.00
dura mater, adult, donor1	10041-101F5	200.44	36.17	8.42	10.24	2.89	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	90.16	6.44	8.66	11.10	0.22	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	124.09	20.78	6.73	11.32	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	78.93	25.90	11.72	4.93	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	76.59	15.44	7.87	6.96	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	66.69	12.04	9.88	5.56	1.54	0.00
embryonic pancreas cell line:2C6	10603-108E9	81.43	18.39	11.82	9.19	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	102.91	7.71	5.36	4.02	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	83.01	15.77	9.24	8.16	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	88.45	14.96	2.41	3.38	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	72.81	9.23	9.45	7.78	1.67	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	125.71	15.29	13.86	12.32	1.54	0.44
epididymis, adult	10197-103E8	138.77	16.74	14.44	9.42	3.14	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	66.00	29.10	7.10	3.37	0.53	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	119.55	29.49	8.65	7.86	1.97	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	95.40	12.19	17.95	15.86	0.26	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	83.56	7.48	18.90	16.04	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	93.43	11.09	17.81	15.57	0.11	0.11
esophagus, adult, pool1	10015-101C6	85.15	17.52	8.49	7.64	0.85	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	96.81	37.70	3.76	3.01	0.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	50.71	24.15	14.49	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	42.08	14.73	2.10	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	59.53	14.88	2.98	8.93	0.00	0.00
eye - muscle superior, donor2	10297-104G9	73.38	17.20	4.59	10.32	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	43.72	14.57	1.46	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	77.54	25.17	7.12	5.85	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	49.37	7.95	5.64	3.08	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	52.23	11.63	4.75	2.85	0.71	0.47
frontal lobe, adult, pool1	10040-101F4	51.79	12.95	2.81	3.19	0.56	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	466.59	41.73	20.72	31.23	1.20	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	110.73	11.52	10.15	7.31	2.93	0.55
gall bladder, adult	10198-103E9	109.37	10.14	9.66	7.48	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	257.15	15.57	7.52	7.52	4.83	0.54
gamma delta positive T cells, donor2	11938-126A3	181.52	15.31	7.84	10.46	2.99	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	65.27	6.13	5.70	4.01	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	50.29	4.64	3.09	2.71	0.39	0.00
gastric cancer cell line:AZ521	10549-107H9	131.66	15.25	9.67	9.84	1.15	0.49
gastric cancer cell line:GSS	10560-108A2	59.49	46.68	2.75	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	180.94	36.32	18.05	16.45	2.51	1.14
giant cell carcinoma cell line:LU65	10487-107B1	47.96	6.20	4.36	3.90	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	211.06	50.11	12.74	12.88	1.82	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	49.14	2.99	12.97	10.97	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	56.89	21.95	5.81	4.86	0.84	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	58.56	20.93	6.88	5.90	1.83	0.00
glioblastoma cell line:T98G	10485-107A8	303.86	16.45	30.57	34.22	3.75	1.43
glioma cell line:GI-1	10413-106B8	334.47	42.76	26.94	32.80	6.44	1.46
globus pallidus - adult, donor10196	10175-103C4	38.63	8.02	5.83	2.92	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	100.32	19.28	3.66	5.37	0.98	0.00
globus pallidus, adult, donor10258	10367-105F7	47.92	15.06	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	37.84	15.99	0.53	2.66	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	516.35	83.20	14.68	19.58	12.24	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	196.71	21.86	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	94.08	15.68	5.23	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	103.36	16.96	8.64	8.00	1.60	0.64
hIPS +CCl2, biol_rep1	14383-156B9	38.11	31.68	3.67	4.13	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	27.44	35.21	3.20	2.74	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	34.78	28.34	3.22	5.15	0.00	0.00
hIPS, biol_rep1	14380-156B6	30.18	27.31	4.31	5.75	2.87	0.00
hIPS, biol_rep2	14381-156B7	21.95	24.69	4.12	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	29.79	14.35	5.52	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	35.06	3.45	1.15	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	91.78	16.14	6.58	5.38	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	61.19	9.94	5.49	5.49	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	169.03	19.98	5.83	5.83	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	54.07	13.67	5.51	3.47	0.61	0.41
heart, adult, diseased, donor1	10051-101G6	41.73	7.66	3.41	3.83	0.43	0.00
heart, adult, pool1	10016-101C7	120.28	14.95	3.68	6.44	0.92	0.69
heart, fetal, pool1	10046-101G1	96.42	15.09	8.32	7.19	1.75	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	205.79	27.46	18.82	15.12	4.63	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	97.51	7.14	26.16	13.08	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	131.82	13.92	18.12	14.70	1.33	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	149.41	13.72	18.33	12.74	0.61	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	137.63	16.27	16.17	12.73	1.52	0.61
hepatoma cell line:Li-7	10484-107A7	119.22	6.12	20.35	19.24	0.44	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	67.94	8.94	6.43	5.43	0.90	0.10
hippocampus - adult, donor10196	10169-103B7	31.23	10.41	1.89	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	73.07	12.86	4.29	6.53	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	17.93	5.48	1.99	2.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	25.03	10.57	2.47	1.06	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	63.48	31.74	2.44	2.44	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	44.38	25.53	2.16	2.95	0.39	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	44.18	28.69	1.27	4.06	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.58	11.28	5.64	6.77	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	41.06	10.07	7.75	5.68	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	46.31	17.08	6.45	8.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	33.28	10.80	6.42	7.59	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	41.79	11.42	9.05	7.54	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	39.20	7.51	7.92	6.26	0.42	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	54.70	17.29	8.76	7.58	0.47	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	48.86	11.25	5.79	4.98	0.32	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	53.19	18.85	6.73	12.79	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.18	23.47	2.19	3.13	0.78	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.36	23.58	2.95	2.46	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	39.27	23.56	0.87	6.11	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	47.92	20.24	7.25	8.02	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	44.04	18.32	9.59	9.59	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	42.98	17.49	9.00	8.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	36.55	18.84	5.84	5.09	1.32	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	45.93	18.64	5.46	3.18	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.21	13.78	2.51	4.70	1.88	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	54.05	16.98	4.08	4.08	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	51.38	15.68	5.23	4.06	1.45	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	34.68	14.95	3.29	2.69	0.60	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	45.82	28.27	2.59	2.77	1.29	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	33.66	33.38	3.71	2.85	0.86	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	46.55	30.22	3.67	3.67	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	48.59	13.38	4.58	4.58	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	46.56	16.47	7.60	3.48	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	42.06	13.01	5.14	3.63	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	37.75	11.38	4.65	8.79	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.22	7.97	5.98	9.30	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	30.01	11.54	4.87	3.85	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	53.43	11.50	6.90	5.62	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	46.95	19.69	6.82	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	40.33	17.47	6.05	4.37	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	41.78	26.08	3.62	5.07	0.48	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	39.66	29.41	3.12	4.90	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	40.98	24.39	2.44	1.46	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	48.90	17.42	3.97	8.25	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	81.33	35.79	9.76	22.77	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	48.65	12.91	7.94	5.63	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	48.71	8.21	7.11	10.40	1.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	37.64	9.77	8.69	6.88	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	27.40	7.12	3.56	6.41	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	36.99	15.51	4.77	8.35	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	61.21	16.12	8.94	7.18	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	30.17	8.89	4.58	4.58	0.81	0.00
immature langerhans cells, donor1	11904-125F5	68.77	5.57	5.81	5.57	1.45	0.48
immature langerhans cells, donor2	11905-125F6	29.31	3.17	3.17	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	50.63	12.11	3.03	2.84	0.28	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	44.55	4.23	35.12	11.71	0.33	0.00
kidney, adult, pool1	10017-101C8	223.58	33.34	20.93	19.02	1.70	0.70
kidney, fetal, pool1	10045-101F9	134.47	25.32	12.03	10.68	1.13	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	189.17	11.93	22.87	15.20	2.84	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	31.52	4.98	4.70	5.94	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	72.48	13.58	4.77	4.22	2.39	0.92
left atrium, adult, donor1	10079-102A7	44.13	11.99	6.54	3.81	1.63	1.09
left ventricle, adult, donor1	10078-102A6	41.46	8.09	3.03	3.54	2.53	0.00
leiomyoblastoma cell line:G-402	10721-110A1	87.83	13.95	7.66	3.83	1.37	1.09
leiomyoma cell line:10964C	10569-108B2	75.08	11.50	5.39	2.51	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	100.54	11.96	6.52	5.98	1.09	0.00
leiomyoma cell line:15425	10571-108B4	75.52	12.87	6.56	4.61	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	323.82	6.35	31.75	19.05	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	115.01	2.09	2.09	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	95.86	8.97	10.63	7.32	0.59	0.12
liposarcoma cell line:KMLS-1	10782-110G8	99.04	9.06	8.90	7.34	1.09	0.00
liposarcoma cell line:SW 872	10726-110A6	98.45	17.18	21.32	13.04	3.66	1.95
liver, adult, pool1	10018-101C9	362.69	50.40	25.12	25.77	4.38	1.78
liver, fetal, pool1	10086-102B5	63.03	13.17	9.41	6.58	4.70	0.94
locus coeruleus - adult, donor10196	10182-103D2	31.50	10.50	2.33	1.60	0.29	0.00
locus coeruleus, adult, donor10252	10165-103B3	69.76	12.18	1.66	3.51	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	30.75	13.82	4.51	2.26	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	48.37	12.62	1.26	3.36	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	387.23	27.68	30.59	34.74	9.41	2.91
lung adenocarcinoma cell line:PC-14	10408-106B3	37.23	4.83	4.14	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	103.74	13.05	14.24	7.78	0.66	0.00
lung, adult, pool1	10019-101D1	285.04	30.00	10.28	16.18	5.32	2.13
lung, fetal, donor1	10068-101I5	211.20	47.38	13.70	14.84	1.14	0.29
lung, right lower lobe, adult, donor1	10075-102A3	80.19	21.08	14.20	11.00	2.29	0.00
lymph node, adult, donor1	10077-102A5	92.31	15.15	8.99	5.68	2.37	0.00
lymphangiectasia cell line:DS-1	10727-110A7	184.77	5.04	17.97	17.32	3.73	2.41
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	62.63	4.23	7.85	6.19	1.06	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	191.14	26.33	15.29	13.59	2.55	0.00
mature adipocyte, donor1	12231-129F8	100.79	23.98	4.00	11.54	1.78	0.44
mature adipocyte, donor2	12232-129F9	113.73	17.64	7.06	8.92	1.25	0.00
mature adipocyte, donor3	12233-129G1	76.81	19.91	7.35	9.48	0.71	0.24
mature adipocyte, donor4	12234-129G2	94.50	12.90	10.53	7.11	0.79	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	257.32	26.69	29.31	27.64	3.10	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	30.46	7.90	2.26	4.51	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	55.36	9.38	2.57	1.66	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	17.79	6.04	2.54	1.91	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	32.41	9.38	3.41	2.99	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	29.53	8.27	2.19	1.52	0.51	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	61.33	12.52	3.82	5.52	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	25.04	5.78	1.93	5.78	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	43.06	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	25.13	5.38	1.44	2.87	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	41.53	16.87	2.60	5.84	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	85.45	11.92	5.88	5.11	0.15	0.00
medulla oblongata, adult, pool1	10038-101F2	74.61	19.26	3.10	4.24	0.41	0.00
medulla oblongata, newborn, donor10223	10361-105F1	52.42	19.79	4.51	6.94	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	69.97	21.26	2.21	3.32	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	136.21	28.25	9.54	8.07	0.98	0.12
melanoma cell line:COLO 679	10514-107E1	70.87	5.46	8.62	6.32	0.86	0.43
melanoma cell line:G-361	10465-106H6	81.44	16.29	5.70	4.07	0.81	0.27
meningioma cell line:HKBMM	10691-109F7	129.53	9.41	5.61	5.97	2.89	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	59.04	12.34	9.69	5.29	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	55.21	9.33	8.30	6.22	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	143.15	11.35	8.75	6.60	2.15	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	140.88	9.45	11.82	8.91	2.54	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	91.52	8.70	2.48	6.21	1.66	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	129.66	5.06	8.15	8.99	0.42	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	192.18	8.28	10.21	12.52	2.50	1.73
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	169.36	10.41	15.27	11.80	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	265.69	15.28	8.24	15.79	6.52	2.23
mesenchymal precursor cell - cardiac, donor2	11753-123G7	129.28	8.05	5.64	5.29	0.69	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	120.43	9.82	9.15	7.16	1.86	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	164.88	8.78	7.02	9.05	2.43	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	151.65	11.67	7.40	9.39	1.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	146.23	19.10	4.94	6.59	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	150.13	13.01	11.35	9.13	1.52	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	130.21	16.76	6.28	3.49	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	166.39	11.43	6.33	6.94	1.63	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	145.58	16.89	8.27	6.83	2.52	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	128.28	10.34	4.24	5.79	1.76	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	124.48	13.91	5.70	9.58	0.46	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	190.90	12.59	14.26	14.68	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	154.52	11.06	6.28	7.92	3.44	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	174.27	13.65	9.02	10.15	3.06	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	173.04	22.09	7.00	8.10	2.58	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	150.52	13.74	6.58	15.17	1.72	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	104.41	12.21	9.26	6.74	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	102.75	11.42	5.94	6.39	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	104.62	13.56	7.93	5.88	0.51	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	121.72	15.18	7.33	8.90	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	121.08	16.94	4.31	6.78	0.92	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	109.91	13.89	5.18	5.88	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	112.71	15.91	4.74	9.82	1.02	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	112.39	12.58	6.29	6.29	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	94.53	16.22	6.95	6.02	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	142.19	14.42	6.92	6.92	2.31	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	125.38	16.29	7.59	5.58	0.89	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	112.00	17.06	5.77	7.45	3.12	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	146.67	26.40	5.87	8.07	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	114.46	15.10	7.05	5.03	0.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	104.80	14.74	4.91	6.96	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	116.84	18.04	8.16	5.58	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	114.85	27.34	5.47	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	77.47	15.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	100.36	15.91	7.79	4.55	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	81.48	11.64	11.64	5.82	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	100.22	12.26	13.33	7.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	98.13	15.54	8.18	4.91	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	108.06	18.66	7.00	8.16	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	88.15	12.59	2.10	8.39	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	102.33	13.91	0.00	5.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	95.34	14.30	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	96.65	15.42	7.12	6.52	1.78	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	106.01	23.15	15.84	4.87	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	96.91	23.44	6.33	6.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	95.54	10.69	5.52	12.07	1.72	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	105.31	6.45	8.60	10.75	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	83.83	0.00	3.99	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	92.98	6.89	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	79.46	4.89	7.74	3.67	1.22	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	85.01	9.53	3.18	5.56	3.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	66.03	5.90	4.13	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	67.95	7.79	4.05	4.68	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	56.14	5.35	0.00	1.34	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	74.51	2.37	5.91	5.91	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	77.04	10.27	5.14	7.70	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	70.22	8.26	4.13	3.44	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	54.92	11.38	4.45	2.47	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	45.98	14.58	10.09	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	50.25	7.00	5.72	3.82	3.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	50.78	10.48	3.22	4.03	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	8.72	6.54	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	7.60	5.07	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	78.90	6.07	6.07	9.71	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	76.82	4.52	13.56	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	56.83	11.53	5.77	7.41	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	125.60	19.25	9.72	10.32	1.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	101.57	13.30	5.84	9.09	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	141.59	6.11	9.17	8.15	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	164.80	20.89	13.93	13.93	3.87	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	195.37	51.03	18.90	12.05	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	142.71	35.91	20.39	17.38	4.63	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	132.48	12.82	12.82	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	194.71	12.23	15.82	12.43	0.51	0.21
mesothelioma cell line:Mero-25	10850-111F4	73.76	5.90	14.30	13.39	2.04	0.68
mesothelioma cell line:Mero-41	10851-111F5	132.99	6.60	9.53	10.27	1.22	0.24
mesothelioma cell line:Mero-48a	10852-111F6	157.88	9.08	12.62	18.38	0.66	0.66
mesothelioma cell line:Mero-82	10853-111F7	129.04	7.10	14.98	14.72	1.84	0.79
mesothelioma cell line:Mero-83	10854-111F8	151.50	15.66	13.79	10.55	0.85	0.34
mesothelioma cell line:Mero-84	10855-111F9	62.18	10.36	3.54	4.04	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	357.36	21.74	38.72	35.61	14.08	3.52
mesothelioma cell line:NCI-H2052	10847-111F1	164.99	19.55	13.09	13.91	3.64	2.32
mesothelioma cell line:NCI-H226	10846-111E9	119.27	7.42	19.55	16.47	1.45	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	70.55	7.35	9.57	6.32	3.07	1.02
mesothelioma cell line:NCI-H28	10845-111E8	136.39	9.16	10.18	13.74	1.02	0.00
mesothelioma cell line:No36	10857-111G2	43.71	12.40	2.94	3.59	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	66.93	2.98	6.23	7.04	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	32.82	4.03	4.41	3.07	0.77	0.38
migratory langerhans cells, donor2	11902-125F3	63.74	5.86	6.84	5.25	1.95	0.24
migratory langerhans cells, donor3	11903-125F4	61.56	7.90	5.56	3.77	2.15	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	104.15	10.77	5.55	9.47	0.65	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	74.18	9.33	8.05	4.24	1.27	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	75.33	12.21	5.99	4.15	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	53.47	3.23	4.19	3.62	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	175.55	28.83	7.58	10.90	1.11	0.18
myeloma cell line:PCM6	10474-106I6	181.06	11.46	18.38	14.03	2.77	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	75.08	17.76	12.68	9.64	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	112.19	12.55	11.57	10.20	1.57	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	144.29	13.48	6.91	4.79	1.89	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	132.30	16.77	4.04	5.00	1.91	0.15
nasal epithelial cells, donor2	12227-129F4	185.47	14.35	8.83	4.97	3.31	1.10
neuroblastoma cell line:CHP-134	10508-107D4	55.44	11.73	11.50	11.04	0.46	0.46
neuroblastoma cell line:NB-1	10539-107G8	54.82	14.22	4.68	5.24	0.37	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	117.25	10.97	14.55	13.50	1.05	0.00
neuroblastoma cell line:NH-12	10555-107I6	46.59	22.36	5.40	5.03	0.56	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	60.26	7.83	3.08	3.80	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	89.49	12.51	4.75	4.75	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	56.76	7.04	1.61	2.62	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	97.27	47.05	8.90	3.18	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	119.77	13.57	13.31	12.78	1.60	0.27
neutrophil PMN, donor1	12133-128D9	119.00	14.87	14.87	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	85.24	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	228.31	33.15	37.21	35.68	8.96	2.54
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	52.03	9.61	7.20	8.01	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	237.57	22.76	15.07	15.39	4.81	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	677.93	18.92	27.59	47.30	5.78	1.84
nucleus accumbens, adult, pool1	10037-101F1	53.06	15.47	3.56	2.91	0.37	0.00
occipital cortex - adult, donor10196	10172-103C1	18.54	14.42	2.06	6.18	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	78.09	11.00	5.64	5.90	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	30.57	6.91	1.09	0.73	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	27.81	8.13	2.89	2.10	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	27.46	8.58	5.15	1.72	0.43	0.00
occipital pole, adult, pool1	10036-101E9	30.35	9.54	2.21	1.34	0.00	0.00
olfactory region, adult	10195-103E6	35.73	12.23	1.91	2.87	0.57	0.00
optic nerve, donor1	10277-104E7	44.02	18.01	4.00	8.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	210.05	10.37	47.96	42.49	7.86	3.87
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	128.87	13.60	15.80	16.76	1.79	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	107.35	10.16	14.56	9.48	1.02	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	148.78	11.09	28.88	19.52	0.81	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	118.17	11.76	9.70	9.11	0.88	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	143.89	54.19	11.21	6.54	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	145.05	11.45	11.66	17.18	2.97	0.42
ovary, adult, pool1	10020-101D2	118.54	24.90	6.64	6.38	0.96	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	87.81	6.78	5.87	3.30	1.65	0.55
pancreas, adult, donor1	10049-101G4	291.60	44.21	31.04	20.69	8.47	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	67.93	7.27	13.70	8.95	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	102.72	8.86	18.74	13.97	0.51	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	290.60	21.86	15.40	13.25	4.31	0.99
paracentral gyrus, adult, pool1	10035-101E8	47.04	12.45	3.39	2.38	0.27	0.00
parietal cortex, adult, donor10258	10373-105G4	35.23	15.41	1.47	2.94	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	6.58	4.70	2.82	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	50.17	8.27	3.99	2.85	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	46.09	11.10	3.00	2.03	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	32.97	13.58	5.82	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	29.16	10.47	2.62	2.62	0.00	0.37
parotid gland, adult	10199-103F1	421.80	43.78	27.13	30.22	4.32	0.00
penis, adult	10200-103F2	77.88	18.26	5.91	2.69	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	134.25	29.94	3.16	4.83	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	333.64	23.17	46.19	44.73	13.84	7.58
pineal gland - adult, donor10196	10179-103C8	31.61	14.19	3.23	1.94	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	79.95	26.65	5.33	4.15	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	48.28	10.03	3.14	2.51	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	141.65	29.34	7.08	5.06	15.18	4.05
pituitary gland, adult, donor10252	10162-103A9	220.46	60.98	15.64	8.34	2.61	0.00
pituitary gland, adult, donor10258	10378-105G9	104.70	32.35	11.92	1.70	6.81	3.40
placenta, adult, pool1	10021-101D3	159.00	18.60	20.75	10.86	1.18	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	84.75	4.50	13.11	11.52	4.90	2.38
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	117.04	19.61	9.03	8.25	1.40	0.16
pons, adult, pool1	10033-101E6	52.42	13.43	2.24	2.84	0.34	0.00
postcentral gyrus, adult, pool1	10032-101E5	40.10	10.46	2.09	2.09	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	596.05	127.58	8.37	25.10	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	137.70	16.52	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	140.83	11.74	0.00	0.00	35.21	0.00
prostate cancer cell line:DU145	10490-107B4	204.95	39.62	17.19	13.84	0.87	0.00
prostate cancer cell line:PC-3	10439-106E7	344.49	50.28	22.14	21.60	1.27	0.36
prostate, adult, pool1	10022-101D4	125.34	18.23	10.16	8.16	1.63	0.27
putamen, adult, donor10196	10176-103C5	35.41	10.86	2.36	1.89	0.47	0.00
putamen, adult, donor10252	10152-102I8	52.94	21.57	0.00	3.92	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	14.21	2.19	3.28	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	31.65	11.84	2.42	1.69	0.00	0.00
putamen, newborn, donor10223	10365-105F5	12.74	11.24	3.00	1.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	209.18	21.24	13.09	14.55	3.49	0.87
rectum, fetal, donor1	10067-101I4	82.07	20.86	13.91	5.56	4.17	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	432.69	20.99	26.92	31.16	4.45	2.76
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	112.67	4.56	2.49	4.56	0.41	0.00
retina, adult, pool1	10030-101E3	106.16	28.23	7.45	5.96	0.89	0.40
retinoblastoma cell line:Y79	10475-106I7	68.07	11.95	8.31	9.09	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	35.04	16.72	5.16	1.23	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	143.41	13.50	12.09	6.75	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	205.38	14.40	10.61	17.43	3.79	1.52
salivary acinar cells, donor1	11771-123I7	68.47	6.64	3.56	2.91	0.16	0.16
salivary acinar cells, donor2	11772-123I8	72.70	7.30	7.44	3.99	0.41	0.28
salivary acinar cells, donor3	11773-123I9	60.25	9.27	6.62	3.97	0.00	1.32
salivary gland, adult, pool1	10093-102C3	287.69	32.03	40.04	26.31	2.29	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	89.37	11.30	5.65	4.55	1.01	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	92.16	9.64	6.00	4.35	0.71	0.00
seminal vesicle, adult	10201-103F3	167.72	20.63	30.69	13.23	3.70	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	256.04	16.03	29.64	29.88	3.40	2.92
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	82.79	18.37	7.05	5.28	0.75	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	85.30	29.10	4.01	4.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	132.04	6.72	7.12	8.06	0.81	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	87.10	3.32	17.57	15.69	0.33	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	60.25	2.97	9.55	8.13	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	24.12	2.84	1.42	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	62.61	5.64	5.64	4.20	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	27.14	6.03	9.05	6.03	1.01	0.00
skin, adult, donor1	10074-102A2	40.71	27.14	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	90.27	27.77	13.89	10.10	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	44.03	10.67	13.01	9.34	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	73.44	18.60	5.36	4.10	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	123.55	44.52	7.13	7.71	0.96	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	65.27	12.36	12.53	9.40	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	171.79	32.65	3.06	4.66	2.73	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	78.45	16.56	19.61	11.99	2.83	0.22
small intestine, adult, pool1	10024-101D6	175.94	15.41	30.58	24.13	1.55	0.36
small intestine, fetal, donor1	10064-101I1	113.27	11.30	18.67	14.00	2.21	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	129.25	6.67	24.62	19.49	2.56	0.51
smooth muscle, adult, pool1	10048-101G3	62.29	9.30	6.98	4.65	1.03	0.00
somatostatinoma cell line:QGP-1	10781-110G7	58.96	4.56	10.18	9.65	2.41	0.00
spinal cord - adult, donor10196	10181-103D1	39.69	13.76	4.82	3.67	1.15	0.23
spinal cord, adult, donor10252	10159-103A6	88.32	16.56	5.52	7.10	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	30.44	22.14	3.46	2.08	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	82.94	21.95	8.54	7.32	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	76.23	15.61	4.59	5.51	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	155.93	18.22	13.44	10.75	3.14	1.34
spleen, adult, pool1	10025-101D7	183.70	16.63	9.91	9.03	2.42	1.10
spleen, fetal, pool1	10044-101F8	119.26	14.06	6.99	6.44	1.19	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	74.32	7.25	6.00	5.28	0.83	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	97.98	12.53	20.70	11.01	0.95	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	72.34	35.29	9.44	3.49	0.70	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	87.18	10.16	6.65	5.86	1.17	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	126.18	12.49	23.98	22.29	1.13	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	76.25	17.37	6.35	5.93	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	72.77	12.69	31.73	14.38	1.27	0.00
stomach, fetal, donor1	10062-101H8	97.19	29.90	21.36	12.82	4.27	1.07
submaxillary gland, adult	10202-103F4	226.16	21.08	22.79	17.09	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	96.79	11.63	3.53	5.82	0.62	0.21
substantia nigra, adult, donor10258	10371-105G2	19.14	12.93	1.03	6.21	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	40.98	12.72	4.95	4.24	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	99.50	26.82	8.71	7.80	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	37.81	9.75	2.12	1.36	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	35.61	7.12	4.99	3.56	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	45.27	10.11	1.76	2.20	0.44	0.00
tenocyte, donor1	11763-123H8	250.31	24.09	9.77	17.46	5.24	1.75
tenocyte, donor2	11765-123I1	291.85	14.50	10.30	19.08	3.43	0.00
tenocyte, donor3	11768-123I4	202.38	14.09	7.78	12.23	1.11	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	61.87	6.80	5.78	5.44	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	43.78	3.24	5.24	5.40	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	77.33	23.87	5.42	2.94	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	211.37	36.69	13.84	13.71	1.02	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	38.57	20.04	1.51	3.03	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	115.50	5.45	8.62	10.69	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	90.22	16.29	4.89	4.56	0.00	0.00
testis, adult, pool1	10026-101D8	139.80	55.08	7.30	7.84	3.01	2.79
testis, adult, pool2	10096-102C6	73.08	53.68	7.22	4.51	2.26	1.35
thalamus - adult, donor10196	10168-103B6	26.50	22.08	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	84.55	12.97	2.81	5.47	0.00	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	40.03	13.86	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	22.73	8.07	2.96	2.47	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	21.86	10.36	2.30	1.73	0.58	0.00
throat, adult	10209-103G2	89.38	12.48	8.99	5.49	1.00	0.50
throat, fetal, donor1	10061-101H7	82.88	20.42	18.28	7.31	1.52	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	30.21	5.17	3.58	1.99	0.79	0.00
thymus, adult, pool1	10027-101D9	180.74	40.46	19.98	17.40	1.49	0.30
thymus, fetal, pool1	10043-101F7	141.52	18.91	13.92	12.05	1.35	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	152.90	25.66	20.87	13.30	4.12	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	123.21	17.88	11.31	9.50	1.26	0.56
thyroid, adult, pool1	10028-101E1	258.76	35.09	26.87	18.01	3.17	0.47
thyroid, fetal, donor1	10060-101H6	84.11	20.57	17.93	10.28	1.85	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	83.15	15.40	3.08	12.32	6.16	0.00
tongue, adult	10203-103F5	59.31	12.09	5.81	5.58	0.70	0.23
tongue, fetal, donor1	10059-101H5	59.90	18.13	9.46	8.67	1.58	0.79
tonsil, adult, pool1	10047-101G2	150.96	15.63	12.52	9.32	1.60	0.20
trachea, adult, pool1	10029-101E2	174.07	19.22	13.25	11.78	1.64	0.65
trachea, fetal, donor1	10058-101H4	101.56	20.39	13.85	7.31	1.54	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	179.26	12.40	12.75	12.40	1.77	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	151.47	23.30	15.70	11.25	2.23	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	201.50	34.00	8.77	5.95	2.35	0.78
tridermal teratoma cell line:HGRT	10694-109G1	175.03	24.73	11.42	5.71	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	131.29	15.49	16.85	10.33	3.81	1.10
umbilical cord, fetal, donor1	10057-101H3	66.77	25.04	14.61	2.09	4.17	0.00
uterus, adult, pool1	10100-102D1	134.11	24.91	12.29	9.38	2.22	0.17
uterus, fetal, donor1	10055-101H1	99.31	23.04	14.33	9.21	1.54	0.51
vagina, adult	10204-103F6	102.10	14.86	8.40	6.46	1.29	0.65
vein, adult	10191-103E2	96.67	10.52	8.55	5.48	0.66	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	41.12	2.40	3.47	2.94	1.07	0.00